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Available online 13 March 2007After Golgi–Cajal mapped neural circuits, the discovery and mapping of the central
monoamine neurons opened up for a new understanding of interneuronal communication
by indicating that another form of communication exists. For instance, it was found that
dopamine may be released as a prolactin inhibitory factor from the median eminence,
indicating an alternative mode of dopamine communication in the brain. Subsequently,
the analysis of the locus coeruleus noradrenaline neurons demonstrated a novel type of
lower brainstem neuron that monosynaptically and globally innervated the entire CNS.
Furthermore, the ascending raphe serotonin neuron systems were found to globally
innervate the forebrain with few synapses, and where deficits in serotonergic function
appeared to play a major role in depression. We propose that serotonin reuptake
inhibitors may produce antidepressant effects through increasing serotonergic
neurotrophism in serotonin nerve cells and their targets by transactivation of receptor
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18 B R A I N R E S E A R C H R E V I E W S 5 5 ( 2 0 0 7 ) 1 7 – 5 4chemical neuroanatomical work on the monoamine neurons, involving primitive nervous
systems and analysis of peptide neurons, indicated the existence of alternative modes of
communication apart from synaptic transmission. In 1986, Agnati and Fuxe introduced
the theory of two main types of intercellular communication in the brain: wiring and
volume transmission (WT and VT). Synchronization of phasic activity in the monoamine
cell clusters through electrotonic coupling and synaptic transmission (WT) enables
optimal VT of monoamines in the target regions. Experimental work suggests an
integration of WT and VT signals via receptor–receptor interactions, and a new theory
of receptor–connexin interactions in electrical and mixed synapses is introduced.
Consequently, a new model of brain function must be built, in which communication
includes both WT and VT and receptor–receptor interactions in the integration of signals.
This will lead to the unified execution of information handling and trophism for optimal
brain function and survival.
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Golgi's and Cajal's outstanding and classic contributions to
the neural circuit mapping are well known. As to the
complementarity of their views on brain communication,
the reader is referred to the Agnati et al. paper in this special
issue covering one century of progress in neuroscience. This
review deals with the breakthrough in chemical neuroanat-
omy given by the Swedish groups of neurobiologists, and
their subsequent development of new concepts on inter-
cellular communication. These researchers presented the
first original mapping of transmitter-identified neural cir-
cuits in the brain. The discovery and mapping of central
monoamine neurons (Dahlström and Fuxe, 1964a,b, 1965;
Fuxe, 1963, 1964, 1965a,b; Carlsson et al., 1962, 1964; Andén et
al., 1964a, 1965a) opened up a new understanding of
interneuronal communication by giving indications that the
synapse, termed so by Sherrington to describe the nexus
between two neurons (see Fig. 1), is not the only existing
form of interneuronal communication. The ground-breaking
discovery of central monoamine neurons paved the way for
our present knowledge on neuropsychiatric diseases (e.g.,
Parkinson's disease, schizophrenia and depression) and
contributed to the development of new concepts which
have been introduced as the result of common and equal
efforts by Agnati and Fuxe (see also Agnati et al., this special
issue). In particular, these authors have proposed the
existence of:(i) Two complementary modes of brain communication:
wiring versus volume transmission (WT and VT), with
volume transmission taking place in the extracellular
fluid (ECF) and cerebrospinal fluid (CSF) of the central
nervous system (see Agnati et al., 1986a; Agnati and
Fuxe, 1996).
(ii) Receptor–receptor interactions (Agnati et al., 1980; Fuxe
et al., 1981; Fuxe and Agnati, 1985), which represent a
mechanism to integrate signals at the plasma mem-
brane level via formation of heteromers.
(iii) Receptor mosaics (RM) in the plasma membrane (high-
order heteromers), which may represent a molecular
basis of learning and memory (Agnati et al., 1982,
2003b).
(iv) Global molecular networks (GMNs) in the brain (Agnati
et al., 2006c, 2007), which postulates the existence of
intracellular and extracellular three-dimensional mole-
cular networks, built up mainly of proteins and carbo-
hydrates, that interact at the plasmamembrane to form
GMNs pervading the entire central nervous system. Itmay contribute to the “binding phenomenon” and the
glio-neuronal network morphology and function.
The major part of this review will deal with the Agnati and
Fuxe proposal of the two complimentary modes of inter-
cellular communication in the brain (concept (i) above).
Volume transmission makes communication possible
between all the cells of the brain via diffusion and flow of
neurotransmitters, neuromodulators and trophic factors in
the extracellular fluid (ECF) and cerebrospinal fluid (CSF),
respectively, where they act as VT signals enabling informa-
tion handling and trophic communication between all cells,
including neuron–glia and glia–glia interactions. Criteria for
VT features and experimental evidence for its existence and
its functional implications will be provided, with VT becom-
ing integrated with WT via receptor–receptor interactions
which are based on the existence of heteromers and receptor
mosaics located synaptically and extrasynaptically (see books
edited by Fuxe and Agnati, 1991b; Agnati et al., 2000a). Also,
the impact of G-protein-coupled receptor/receptor tyrosine
kinase interactions as mediators of VT signaling in neuronal
plasticity and trophism is introduced, and the critical role of
receptor–receptor interactions as integrators of WT and VT is
emphasized. A new hypothesis on the functional implica-
tions of receptor–receptor interactions at the level of elec-
trical and mixed synapses is proposed, which could play a
role in synchronization of entire brain areas. Hence, it could
be involved in the so-called “binding phenomenon”, which
has been proposed to be the basic mechanism that allows the
creation of a global workspace and eventually of conscious
experience (see, e.g., Agnati et al., 2006a). This new perspec-
tive on information handling and trophism via WT and VT
may have a great impact on neurophysiology, neuropathol-
ogy and neuro-pschopharmacology.2. Discovery and characterization of the
chemical neuroanatomy of neural circuits
based on the Falck–Hillarp technique
for the cellular localization of monoamines
The great neurohistologists Camillo Golgi and Santiago
Ramon y Cajal were the ones who discovered the neuronal
circuits and provided the first neuronal maps of the nervous
system bymeans of the Golgi technique and its modifications,
involving a first step of an osmium–dichromate mixture
followed by a second step of impregnation with a silver nitrate
solution (see DeFelipe and Jones, 1992). For this truly funda-
mental work they received the Nobel Prize in 1906 with the
Fig. 1 – Illustration of the historical development of the
concept of synaptic transmission. (A) Sherrington CS
(1857–1952). (B) Cajal obtained indications that the
relationship between neuronal processes was one of
contiguity and not of continuity. (C) This nexus was called
synapse by Sherrington in his book on the “Integrative
Action of the Nervous System” in 1906: “… if at the nexus
between neuron and neuron there does not exist actual
confluence of the conductive part of one cell with the
conductive part of the other,… there must be a surface of
separation… In view, therefore, of the probable importance
physiologically of this mode of nexus between neuron and
neuron it is convenient to have a term for it. The term
introduced has been synapse…”.
Fig. 2 – Dopaminergic nerve cells are seen with greenish CA
fluorescence in their cell bodies and processes in the zona
compacta of the substantia nigra (A9) of the rat, using the
Falck–Hillarp formaldehyde fluorescence method for the
cellular localization of monoamines. Dahlström and Fuxe
(1964a,b), previously unpublished material.
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nervous system”.
Another major breakthrough came with the discovery
and mapping of the central monoamine neurons (Dahlström
and Fuxe, 1964a,b, 1965; Fuxe, 1963, 1964, 1965a,b) based on
the introduction of monoamine transmitter histochemistry,the so-called catecholamine (CA) and 5-hydroxytryptamine
(5-HT) formaldehyde histofluorescence method of Falck and
Hillarp (Falck et al., 1962; see Fuxe and Jonsson, 1973). With
this technique, the hypothalamic noradrenaline (NA) nerve
terminal networks had already been demonstrated in 1962
(Carlsson et al., 1962). The standardization of the histo-
chemical formaldehyde reaction by Hamberger et al. (1965),
including also the role of water, had a strong and persistent
impact for the work in this field. The chemistry of this
method was characterized early on by Falck, Hillarp, Corrodi,
Jonsson and colleagues (see review by Fuxe et al., 1970b;
Fuxe and Jonsson, 1973). The histochemical reaction
between e.g., CA and formaldehyde involves a condensation
of the amine with formaldehyde leading to the formation of
a 1,2,3,4-dihydroisoquinoline, which is subsequently dehy-
drogenated to the corresponding 3,4-dihydroisoquinoline in
a protein promoted reaction. This latter form is in equili-
brium with its quinoidal form, which predominates and is
responsible for the green fluorescence emission at 480 nm
found in the brain sections upon excitation of this
fluorophore.
2.1. The discovery and mapping of the central dopamine,
noradrenaline and 5-hydroxytryptamine neurons
2.1.1. Dopamine neurons
2.1.1.1. The nigro-striatal dopamine pathway. A crucial
observation was the existence of nerve cell bodies in the rat
substantia nigra and especially in the zona compacta with a
green cytoplasmatic CA fluorescence (Fig. 2, Dahlström and
Fuxe, 1964a). By means of biochemical correlates and a
pharmacological analysis, it was shown to represent a
dopamine (DA) fluorescence and became known as the A9
DA cell group (Dahlström and Fuxe, 1964a). A large mass of
diffuse to dotted green CA fluorescence was observed in the
caudate putamen and shown to represent a DA fluorescence
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1965a,b). By means of the method developed by Dahlström
and Fuxe (1964b) using lesions and striatal ablations, it
became possible to visualize the ascending DA fiber bundles
from the substantia nigra to the caudate putamen on the cell
body side of the lesion (Andén et al., 1964b, 1965a,b). Here they
became strongly green fluorescent as a result of the blockade
of the transport of DA storage vesicles in the DA axons to the
terminals, leading to their accumulation in the DA fiber
bundles of the posterior medial forebrain bundle and the
internal capsule. In thisway, the existence of the nigro-striatal
DA pathway was demonstrated, with the lesions also leading
to a marked disappearance of the nigral DA cell bodies
showing DA fluorescence. With this discovery, it became
clear that the disappearance of the nigral DA stores in
Parkinson's disease (Hornykiewicz, 1963) was likely caused
by the degeneration of the nigro-striatal DA pathway in this
disease. This view was further underlined by the work of
Andén et al. (1966b) using mechanical lesions in the rat
indicating a role of this pathway in motor function and by the
elegant work of Ungerstedt (1968, 1971) using 6-OH-DA
induced lesions of the ascending DA pathways.
Another important breakthrough came with the discovery
of striatal islands of DA nerve terminal systems in 1972 with
the Falck–Hillarp technique (Olson et al., 1972; Tennyson et
al., 1972) showing for the first time the organization of the
striatum into two compartments, the diffuse and islandic
compartments. This work was elegantly pursued by Graybiel
and her group (Graybiel and Ragsdale, 1978; Graybiel et al.,
2000) and by Gerfen and his group (Gerfen, 1984, 2000) with
the islands called striosomes (Graybiel's group) or patches
(Gerfen's group) and the remainder called matrix. These
groups established the input/output relationships of the
striatal islands and the expression of a number of markers.
The discovery of the limbic–prefrontal–striatal island circui-
try indicated that the striatal islands participated in reward
based motor learning (Eblen and Graybiel, 1995; Gerfen,
2000), while parallel work indicated that the matrix is
involved in sensory–motor processing (Gerfen, 1993; Canales,
2005). A number of observations have indicated that the
striatal islands play a crucial role in motor learning
responsible for the development of L-dopa induced dyskine-
sias (Graybiel et al., 2000; Agnati et al., 2003b) and habit
acquisition in drug addiction (Graybiel et al., 2000; Everitt and
Robbins, 2005; Canales, 2005). The dopamine D4 receptors
enriched in the striatal islands may have an especially
important role among the D2-like receptors as to the
function of the striatal islands (Rivera et al., 2002). For
further aspects on nigro-striatal DA neurons and Parkinson's
disease, see Fuxe et al. (2006).
2.1.1.2. The meso-limbic dopamine pathway. Large numbers
of CA cell bodies with green CA fluorescence were also
discovered in the ventral tegmental area with the pharmaco-
logical analysis using α-methyl-m-tyrosine, indicating it to be
a possible dopaminergic fluorescence (Dahlström and Fuxe,
1964a). A high density of DA nerve terminals was also
demonstrated with the Falck–Hillarp technique in the nucleus
accumbens and olfactory tubercle forming a large mass of
diffuse to dotted DA fluorescence at these locations (Fuxe,1965a,b). By means of lesions (e.g., between the cell body and
terminal regions in the lateral hypothalamus involving the
medial forebrain bundle), CA fluorescence histochemistry and
biochemical DA and NA analysis, the existence of a DA
pathway from the ventral tegmental area to the nucleus
accumbens and the olfactory tubercle running in the medial
forebrain bundle was discovered, called the meso-limbic DA
pathway (Andén et al., 1965a,b, 1966a,c,d; Fuxe et al., 1970c;
Ungerstedt, 1971). A dysfunction of this DA system was early
on proposed to be involved in mental disorders like schizo-
phrenia (see Fuxe et al., 1970c; Fuxe, 1970), in view of the
demonstration that DA receptor antagonism may be the
mechanism of action for classical antipsychotic drugs like
chlorpromazine and haloperidol as first indicated by Carlsson
and Lindquist in 1963 (see Carlsson, 1988). This work was
further extended in combined functional and neurochemical
experiments by Andén and colleagues (Andén et al., 1966b,
1970). Subsequently, the DA hypothesis of schizophrenia was
strongly supported by the observations that all anti-schizo-
phrenic drugs had the ability to bind and block D2/D3
receptors (Seeman et al., 1975; see Kapur and Mamo, 2003)
and in the brains of schizophrenic patients D2 receptor
occupancy is correlated to antipsychotic drug effects (Farde
et al., 1988; Nordström et al., 1993). In the 1990s, indications for
enhanced striatal DA responsitivity had been obtained in
schizophrenic patients with PET imaging (see Laruelle et al.,
1996, 2003). In 1980, the glutamate hypothesis of schizophre-
nia was introduced (Kim et al., 1980) and was supported by the
observations that the drug phencyclidine promoted psychotic
states and acted as a non-competitive NMDA receptor
antagonist (see Jentsch and Roth, 1999; Svensson, 2000).
It is of particular interest that treatment with this type of
drugs causes a rise of burst firing in the meso-limbic DA
neurons as recorded from the A10 DA cells located in the
ventral tegmental area (Murase et al., 1993), which is related to
a reduction in the prefrontal glutamate input to GABA
interneurons controlling the firing pattern of the VTA DA
cells projecting to subcortical limbic regions (Carr and Sesack,
2000). Such results emphasize an important role of meso-
limbic DA neuron hyperfunction in schizophrenia and block-
ade of D2-like receptors in the limbic subcortical system may
in fact be the major target for known antipsychotic drugs. Of
special importance are the inhibitory D2-like receptors on the
ventral striato-pallidal GABA pathway, operating in a circuit
which via the GABA projection from the ventral pallidum to
themediodorsal thalamic nucleus (Heimer, 2000) regulates the
firing of the cortical glutamate projections from this nucleus.
Thus, blockade of these D2-like receptors by antipsychotic
drugs will increase the activity of these prefrontal glutamate
projections andmay help to copewith sensory overloadwhich
may contribute to the development of psychosis, as first
discussed by Carlsson (1988). It should also be noted that a
reduced prefrontal activity predicts enhanced striatal DA
function in schizophrenia (Meyer-Lindenberg et al., 2002). In
contrast, NMDA receptor antagonists reduce burst firing in the
VTA DA cells projecting to the prefrontal cortex since they
receive direct monosynaptic glutamate projections from the
prefrontal cortex causing their excitation (Murase et al., 1993;
Carr and Sesack, 2000). Thus, hypofrontality in schizophrenia
may produce reduced function in the meso-cortical DA
Fig. 3 – Dopaminergic nerve cells are seen with greenish CA
fluorescence in the cell bodies in the arcuate nucleus (A12)
and themost ventral part of the periventricular hypothalamic
region close to the third ventricle (in the center) just dorsal to
the median eminence of the rat. The DA cell bodies lie in a
nerve terminal plexus of medium density with varicosities
appearing as puncta with strong greenish CA fluorescence.
Falck–Hillarp technique from Dahlström and Fuxe in the
early 1960s previously unpublished material.
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schizophrenia (Jentsch and Roth, 1999; Svensson, 2000).
The major role of the meso-limbic DA afferents in schizo-
phrenia involving mainly D2/D3 receptor mediated effects in
the ventral striatal complex, including the ventral pallidum,
amygdala, extended amygdala and the septal area (Heimer,
2000), may be to regulate the emotional impact of the
subcortical limbic networks on the cerebral cortex, especially
the prefrontal cortex, involving the ventral striatum–ventral
pallidum–mediodorsal thalamic nucleus circuit to the dis-
turbed prefrontal cortex. In line with this view, parts of the
meso-accumbens DA system represent a reward system able
to also predict the time of future rewards (Schultz, 2002;
Montague et al., 1996; Agnati et al., 2007; Guidolin et al., this
special issue), mediating natural rewards like food and the
hedonic effects of drugs of abuse like cocaine (Robinson and
Berridge, 1993; see Hurd, 2006; Ivanov et al., 2006). However, it
is clear that the meso-limbic DA neurons are activated also in
response to negative reinforcement (Fuxe and Hanson, 1967;
see Salamone et al., 1997). Thus, what matters is the salient
nature of the reinforcer (Ungless, 2004). The molecular
mechanisms that lead from acute rewarding effects of drugs
like cocaine to drug addiction are still unclear. They may
involve plastic changes in the receptor networks of the local
circuits in the ventral striatum, with alterations in the D2 and
D3 containing receptor mosaics (RM) and their receptor–
receptor interactions and integrated signaling (RM; high-
order heteromers or homomers), leading to changes in the
gene expression including adapter proteins contributing to
enduring changes in the DA RM, due to their stabilization by
the adapter proteins formed (see Fuxe et al., 2007; Marcellino
et al., 2007). As to genetic risk factors in DA receptor subtypes
and evidence based dopaminergic treatments of substance
abuse disorders, see Hurd (2006) and Ivanov et al. (2006),
respectively.
2.1.1.3. The tubero-infundibular dopamine neurons. Already
in 1963, a substantial number of small-sized nerve cell bodies
with a weak to medium CA fluorescence were observed in the
arcuate nucleus and the ventral part of the periventricular
hypothalamic region (Fig. 3), as well as a strong mass of CA
fluorescence in the external layer of the median eminence,
probably representing densely packed CA nerve terminals as
in the striatum with its dense DA innervations. These results
indicated the existence of tubero-infundibular DA neurons, as
also supported by the pharmacological analysis (Fuxe, 1963,
1964; Fuxe and Hökfelt, 1966; Löfström et al., 1976a). Biochem-
ical correlates were subsequently obtained in collaboration
withWiesel et al. (1978) and also made it possible to develop a
method to determine DA levels and turnover rate in discrete
DA nerve terminal systems by quantitative use of the Falck–
Hillarp DA fluorescence method (Agnati et al., 1979; Anders-
son et al., 1985b). Histofluorimetric quantitation of CA
fluorescence in the median eminence was first made in 1976
(Löfström et al., 1976a,b), demonstrating it as a reliable
method for CA quantitation in discrete terminal systems in
this region. These methods have played an important role in
the characterization of the changes in DA turnover using the
tyrosine hydroxylase inhibition method in the nerve term-
inals of the medial and lateral palisade zone (MPZ and LPZ) ofthe external layer of the median eminence, in various
hormonal states including tonic and phasic hypersecretion
of LHRH. They have amplified the results of the early work
using semiquantitation and pharmacological analysis and
underline an inhibitory role of LPZ DA nerve terminals in
LHRH release and suggest that MPZ DA nerve terminals
release DA as a prolactin inhibitory factor (PIF) into the
hypophyseal portal vessels (for reviews, see Fuxe et al., 1978,
1980a,c, 1985).
DA receptors were subsequently identified in the anterior
pituitary and were shown to inhibit prolactin secretion
(MacLeod and Lehmeyer, 1974). DA were also demonstrated
in the portal vessels (Ben-Jonathan et al., 1977) and in the
hypophysectomized rat, where prolactin produced a rapid and
discrete increase of DA turnover in the MPZ (Andersson et al.,
1981). The involvement of theMPZ DA nerve terminals as a PIF
system was first indicated in the analysis of the nicotine-
induced inhibition of prolactin secretion (Fuxe et al., 1977a).
All these observations have established DA as a PIF, which at
least in the rat appears to be released from the DA nerve
terminals of theMPZ, which in agreement have the highest DA
turnover of all DA terminals so far analyzed (Andersson et al.,
1985b). This research, showing DA to be a neurohormone, had
a substantial impact also on understanding the mode of DA
communication in the brain. It strengthened the idea that DA
may not only operate in synaptic signaling, but also via
diffusion in the extracellular fluid and thus via VT (Agnati et
al., 1986a; see Agnati et al., this issue and below). Similar
conclusions also arose when discovering prolactin-like IR
nerve terminals in the hypothalamus and other parts of the
brain (Fuxe et al., 1977b; Paut-Pagano et al., 1993), indicating
that prolactin may not only be a hormone but also a
transmitter in the brain that may operate via diffusion in the
Fig. 4 – A cluster of noradrenergic nerve cells are seen with
greenish cytoplasmic CA fluorescence in their cell bodies and
processes with perinuclear rings of strong CA fluorescence in
the locus coeruleus of the rat. Falck–Hillarp technique.
Dahlström and Fuxe, 1964a,b, previously unpublished
material.
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1986a; see Agnati et al., this issue and below).
The above neuroendocrine work has emphasized the
importance of special types of local circuits in the external
layer of themedian eminence in understanding the regulation
of hypothalamic hormone release, like the DA regulation of
LHRH release in the LPZ (Fuxe et al., 1980a, 1985; Andersson et
al., 1984). The concept of the existence of “medianosomes”
was introduced, present in the external layer as functional
modules built up of domains of different types of nerve
terminals centered around a hypothalamic hormone-contain-
ing nerve terminal, like the LHRH nerve terminal, and
controlling its release. Medianosomes were postulated to be
the fundamental integrative units in the LPZ and MPZ, where
the brain-borne and blood-borne signals became integrated
with neuronal signals via transmitter receptors and hormonal
receptors like hypothalamic and hypophyseal hormone
receptors in the plasma membranes of the participating
terminals. In view of the existence of different types of
transmitter and hormonal receptors in the various mediano-
somes, their individual regulation could be obtained leading to
an integrated signal capable of releasing the various hypotha-
lamic hormones according to the needs of the organism.
Another important component of the medianosomes is the
tanycytes, which may help in the structural organization of
the medianosomes and also in their regulation by having
transmitter and hormone receptors and releasing modulators
to fine-tune the information handling in these special types of
local circuits (Bjelke and Fuxe, 1993).
In fact, local circuits in the external layer (medianosomes)
are unique in having no synapses and only communicate via
VT signaling, and therefore the term medianosome is more
appropriate. Thus, here all the plasma membrane receptors
are extrasynaptic and are reached by transmitters and
hormones diffusing in the extracellular space around the
terminals and tanycytes. Via diffusion of transmitters and
hypothalamic hormones from one type of medianosome to an
adjacent one, different types of medianosomal cross-talk
develop and can assist in causing a coordinated secretion of
hypothalamic hormones. DA terminals appear to participate
in several types ofmedianosomes like the LHRH (Andersson et
al., 1984; Fuxe et al., 1980a, 1985), TRH (Andersson et al., 1985a),
somatostatin (Andersson et al., 1983) and PIF medianosomes,
and in the PIF medianosome they represent the “hub” (crucial)
terminal releasing DA as a PIF. The modulatory role of DA in
the median eminence is also supported by the existence of D1
receptors in this region (Fuxe et al., 1983b) and by the
demonstration of DARPP-32 IR in the tanycytes (Ouimet et
al., 1984). It is of substantial interest that LHRH in the
hypophysectomized rat can produce a rapid increase of DA
turnover in the LPZ DA terminals, indicating that diffusing
LHRH in its medianosome can exert an ultrashort feedback on
its own secretion by increasing DA release from the DA
terminals of the LHRH medianosome via activation of LHRH
receptors (Andersson et al., 1984). This early work is of
fundamental interest and indicated that in the local circuits
of the brain both wiring and volume transmission participate
in information handling (see below). The clinical impact of
dysfunction of the tubero-infundibular DA neurons projecting
to the MPZ releasing DA as a PIF is clear. A deficit in this DAtransmission leads to hyperprolactinemia leading to inhibi-
tion of LHRH and of ovulation. This mechanism may involve
prolactin-induced activation of DA release in the LPZ from the
DA nerve terminals within the LHRH medianosomes (for a
review, see Fuxe et al., 1980a, 1985).
2.1.2. Noradrenaline neurons
2.1.2.1. The locus coeruleus noradrenaline system. The locus
coeruleus was shown to be built up of CA cell bodies in 1964
(Dahlström and Fuxe, 1964a,b), showing a medium to strong
greenish-yellowish CA fluorescence in the cytoplasm mainly
concentrated to perinuclear rings (Fig. 4). The relative slow
recovery of amine fluorescence after α-methyl-m-tyrosine
treatment in the locus coeruleus (group A6) versus themesen-
cephalic and arcuate DA cells made it possible that the CA
fluorescence represented an NA fluorescence. Lesions in the
lateral hypothalamus within the medial forebrain bundle and
in the caudal tegmentum of the midbrain, in combination
with CA histochemical fluorescence and DA and NA biochem-
ical analysis, provided evidence of the disappearance of NA
but not of DA stores and of extrastriatal CA nerve terminals in
the tel- and diencephalon (Fuxe, 1965a,b), correlated with
retrograde changes in the A6 cells, initially characterized also
by increases in CA fluorescence (Andén et al., 1966a,b). These
results indicated that the locus coeruleus was built up of NA
cells, subsequently confirmed with dopamine-β-hydroxylase
immunocytochemistry (Fuxe et al., 1970a) and gave rise to
ascending NA pathways which could be elegantly visualized
caudal to lesions in the medial forebrain bundle and the
tegmentum as swollen strongly green fluorescent CA axons
that could be traced towards the locus coeruleus as a dorsal
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A6 NA cell group via long ascending NA axons appeared to
monosynaptically give rise to large numbers of extrastriatal
fine varicose NA terminals in the tel- and diencephalon.
Of special interest were the findings of Andén et al. (1966d),
who demonstrated that after large lesions in the border
between di- and mesencephalon, increased CA fluorescence
appeared in largenumberof CAnerve terminal networks in the
lowerbrain stem, in the cerebellar cortexandeven in the spinal
cord. These terminals probably represented collateral NA
nerve terminals given off from the ascending NA axons caudal
to the lesion, and showing increased NA levels due to re-
routing of the flow of NA storage vesicles into the collaterals.
These results opened up the possibility that NA cells with
ascending projections in the pons and medulla oblongata
could give rise to a large number of collaterals and also to
descending projections to the spinal cord and projections to
the cerebellum. At this moment of time, at least some NA
neurons in the pons and medulla oblongata represented a
novel type of neuron that couldmonosynaptically and globally
innervate the entire CNS from the spinal cord to the forebrain.
In 1971–72, the evidence emerged that locus coeruleus NA
neurons were indeed giving rise to nerve terminal networks in
the entire cerebral and cerebellar cortex andparticipated in the
innervation of many subcortical and brain stem regions
(Ungerstedt, 1971; Olson and Fuxe, 1971; Maeda and Shimizu,
1972; Lindvall and Björklund, 1974). Furthermore, in 1977 itwas
shown that locus coeruleus gave rise also to large NA
projections to the spinal cord innervating the ventral and
dorsal horns (NygrenandOlson, 1977). Thus,NAneuronsof the
locus coeruleus appear not only to be involved in coordinating
cortical activities to promote tonic arousal (Jouvet, 1972;
Lidbrink and Fuxe, 1973; Fuxe and Lidbrink, 1973), but also to
link such cortical activities to reflex activities in the spinal cord
to improve their performance in states of arousal.
The role of the locus coeruleus NA neurons in arousal was
further clarified by Aston-Jones and Bloom (1981a,b), linking
high firing of these neurons to waking with a reduction of
activity in slow wave sleep and absence of activity in
paradoxical sleep. Relevant sensory stimuli cause their phasic
activation in the awake state. Recently, evidence has been
obtained that the phasic mode of LC activation helps in
optimizing task performance by assisting in the development
of focused attention, the phasic firing being driven by the
outcome of decisionmaking (Aston-Jones and Cohen, 2005a,b;
Aston-Jones, 2005). It is of substantial interest that the
maintenance of LC NA neuron firing and of tonic arousal is
dependent on light exposure, thus contributing to a circadian
regulation of arousal (Gonzalez and Aston-Jones, 2006; Aston-
Jones, 2005). The circuit involved in thismechanism runs from
the suprachiasmatic nucleus via the dorsomedial hypothala-
mic nucleus (DMH) to the LC, with hypocretin cells in the DMH
giving an excitatory input to the LC.
2.1.2.2. The non-locus coeruleus noradrenaline systems.
These systems originate from the remaining NA cell groups
in the medulla oblongata (groups A1 and A2) and pons (A4–
A5, A7 and subcoeruleus area; Dahlström and Fuxe, 1964a,b).
They give rise to ascending and descending projections to the
tel- and diencephalon (Andén et al., 1965b, 1966a,b; Unger-stedt, 1971) and the spinal cord, respectively (Dahlström and
Fuxe, 1965; Nygren and Olson, 1977) as shown in lesion
experiments in combination with the Falck–Hillarp techni-
que. The ascending NA fibers formed a ventral NA bundle
mainly distinct from the dorsal NA bundle in the tegmentum
(Fuxe et al., 1970c; Ungerstedt, 1971) consisting of two
components, the subcoeruleus and the medulla oblongata
(including ventral pons) NA fiber bundles (Maeda and
Shimizu, 1972; Olson and Fuxe, 1972), giving rise to fairly
thick NA nerve terminal plexa with large and strongly
fluorescent varicosities in the hypothalamus, the preoptic
area, the extended amygdala and other parts of the sub-
cortical limbic system (Carlsson et al., 1962; Fuxe, 1965a,b;
Ungerstedt, 1971; Olson and Fuxe, 1972).
The bulbo-spinal NA fibers (Dahlström and Fuxe, 1965)
from these NA cell groups mainly give rise to the NA
innervations of the sympathetic lateral column and of the
dorsal part of the dorsal horn (Nygren and Olson, 1977), with
the preganglionic sympathetic neurons surrounded by den-
sely packed nerve terminals with large varicosities of an
intense green fluorescence. A large number of observations
are compatible with the view that many of these non-LC cells
may give rise to both ascending and descending NA axons,
which via collateralsmay innervate also brain stem nuclei like
the nucleus tractus solitarius, an important visceral center in
the dorsal medulla oblongata (Fuxe, 1965a,b). Thus, these
types of NA neurons may be important coordinators of
autonomic and neuroendocrine functions in central auto-
nomic networks at the hypothalamic–limbic, lower brainstem
and spinal cord level (Olson and Fuxe, 1972). One interesting
cross-talk between the LC and non-LC NA neuron systems at
the network level can occur in the DMH which is richly
innervated by non-LC NA terminals. At this level, the non-LC
NA system can modify the light-activated pathway which
relays in this nucleus on its way to the LC, where it increases
its firing (see above). Thus, non-LC NA systems controlling
visceral and neuroendocrine function can via this cross-talk
also modify the alertness and attention via an indirect
influence on the LC NA neurons, linking autonomic activities
to arousal and cognitive performance. In addition, dysfunction
of the LC and non-LC NA neuron systems has been suggested
to contribute to stress and attention deficit hyperactivity
disorders (ADHD) (Oades et al., 2005), where disturbances in
the meso-limbic-cortical DA neurons also have been consid-
ered as a major mechanism (Forssberg et al., 2006). Nicotine
has been proposed to be a possible treatment of ADHD since it
enhances CA release from these two NA and DA systems
(Granon and Changeux, 2006).
2.1.3. 5-Hydroxytryptamine neurons
The fluorophore formed by the condensation of 5-HT with
formaldehyde with the Falck–Hillarp technique gave upon
excitation rise to a yellowish fluorescence with the filters used
with an emission peak at 530 nm (Falck et al., 1962, for a
review, see Fuxe et al., 1970b). It was again a two-step reaction
with a ring closure leading to the formation of a β-carboline
followed by a secondary dihydrogenation. However, in spite of
improvements of the Falck–Hillarp technique for the cellular
demonstration of 5-HT (Fuxe and Jonsson, 1967) it never
reached the sensitivity of the cellular demonstration of CA.
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bodies in the brainwith their ascending and descending axons
to the tel- and diencephalon and the spinal cord, respectively.
The 5-HT cell bodies were located in the raphe systems of the
lower brainstem, and some were also located in a para-raphe
position. Microspectrofluorimetry further established that the
vast majority of these nerve cells contained 5-HT (Jonsson et
al., 1975). The largest collection of yellow fluorescent 5-HT
nerve cells was found in the dorsal raphe of the midbrain,
where also several subgroups were identified (Fig. 5). The
visualization of the 5-HT nerve cells and their axons was
markedly enhanced by monoamine oxidase inhibition which
allowed to trace e.g., the ascending 5-HT tracts for long
distances rostrally along themedial forebrain bundle and how
they turned dorsally in front of the septal area to sweep back
along the dorsal surface of the external capsule together with
the NA axons running especially in the cingulum (Fig. 5)
(Dahlström and Fuxe, 1964a; Andén et al., 1965a,b, 1966a,b).
Fairly large numbers of varicose yellow fluorescent 5-HT
nerve terminal networks were observed in the lower brain-
stem (Fuxe, 1965b) and especially in the spinal cord (Carlsson
et al., 1964; Fuxe, 1965b; Dahlström and Fuxe, 1965). In
contrast, in the tel- and diencephalon only some nuclei
contained considerable numbers of fine 5-HT nerve terminal
systems, like the suprachiasmatic nucleus (Fuxe, 1965b), while
only scattered and very fine 5-HT terminals were found in the
cortical regions, probably due to the relative insensitivity of
the Falck–Hillarp 5-HT fluorescence technique. It was only
with the introduction of the 5-HT immunofluorescence
technique (Steinbusch et al., 1978) that it became possible to
study the 5-HTnerve terminal networks in considerable detail,
and this was especially true for the tel- and diencephalonFig. 5 – Several clusters of serotonergic nerve cells are seen
with strong yellowish 5-HT fluorescence in the cell bodies
and processes in the dorsal raphe region (B7) of the rat after
monamine oxidase inhibition with nialamide. Three B7
subgroups are seen. Falck–Hillarp technique. Dahlström and
Fuxe, 1964a,b, previously unpublished material.(Steinbusch, 1981; Steinbusch et al., 1981; Steinbusch and
Nieuwenhuys, 1981). 5-HT nerve terminal networks in various
densities and patterns were present in practically all parts of
the brain and the spinal cord, as had previously been found for
the NA nerve terminal networks, underlining their global
innervation of the CNS. For an excellent review, see Jacobs and
Azmitia (1992).
2.1.3.1. The ascending 5-HT pathways. By means of elec-
trical and indolamine neurotoxin (5,6- and 5,7-dihydroxytryp-
tamine) induced lesions, in combination with the 5-HT
histofluorescence method and biochemical techniques with
measurements of 5-HT levels, it became possible to show that
themesencephalic 5-HT cell groups and associated cell groups
in the pons, via large numbers of monosynaptic projections
mainly traveling in known fiber bundles like the medial
forebrain bundle, gave rise to the 5-HT innervation of the
tel- and diencephalon including the cerebral cortex (Andén et
al., 1965b, 1966a,b; Daly et al., 1973, 1974; see Fuxe and Jonsson,
1974). The ascending NA and 5-HT axons from the pons and
medulla oblongata were using similar fiber routes to mono-
synatically and globally but in distinct patterns innervate the
tel- and diencephalon (Fig. 6). The 5-HT cell groups involved
were group B7 in the dorsal raphe and its caudal extension
into the pons, group B6 (caudal dorsal raphe), group B8 in the
area of themedian raphe and the caudal linear nucleus and its
caudal extension into the pons, reaching group B5 (area of
nucleus raphe pontis). The minor B9 cell group located in a
more ventral and rostral position mainly located in the
supralemniscal nucleus was also involved in providing
ascending 5-HT axons.
A major observation was made in 1975 with the demon-
stration that the majority of the serotonin nerve terminals in
the adult rat cortex lacked junctional complexes and thus
were asynaptic (Descarries et al., 1975), and it was suggested
that 5-HT can be liberated from all varicosities. This inter-
pretation was in line with prior results showing that electrical
stimulation of the amygdala leads to reduction of amine
fluorescence in varicosities of brain CA nerve terminals (Fuxe
and Gunne, 1964) due to their excessive release with insuffi-
cient resynthesis and reuptake. Likewise, electrical stimula-
tion in the medulla oblongata leads to reduction of CA and 5-
HT fluorescence in varicosities of NA and 5-HT nerve terminal
networks of the spinal cord (Dahlström et al., 1965). Also, in
the autonomic ground plexus of the iris lacking junctional
complexes, electrical stimulation causes disappearance of
amine fluorescence from practically all varicosities (Malmfors,
1965). Such observations gave experimental support to the
introduction by Agnati and Fuxe and colleagues of the concept
of two modes of communication in the CNS, wiring and
volume transmission (Agnati et al., 1986a; see Fuxe et al.,
1988a,b,c).
2.1.3.2. The bulbo-spinal 5-HT pathways. In 1965, the bulbo-
spinal 5-HT neurons (Dahlström and Fuxe, 1965) were demon-
strated which gave rise to the rich 5-HT terminal spinal
networks built up of varicosities, showing a yellow fluores-
cencewith the Falck–Hillarp technique and found especially in
the ventral and lateral horns (Carlssonet al., 1964; Fuxe, 1965b).
Using various types of spinal cord transections in combination
Fig. 6 – Original schematic description of the DA, NA and
5-HT pathways from 1965. It was prepared by Dahlström and
Fuxe in the spring of 1965 and presented by them at the
Second International Catecholamine Symposium in Milan,
July 4–9, 1965. It was mainly based on papers by Dahlström
and Fuxe (1964a,b, 1965), Fuxe (1963, 1964, 1965a,b), Andén
et al. (1964a,b, 1965a,b, 1966a,b). The long ascending and
descending monosynaptic projections from the lower
brainstem to the tel- and diencephalon and the spinal cord,
respectively, are illustrated as red: DA pathways; green: NA
pathways; yellow: 5-HT pathways.
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monoamine oxidase inhibition, the 5-HT cell groups B1 and
B2 in the area of the nucleus raphe pallidus and of the nucleus
raphe obscurus, respectively, together with the large 5-HT cell
group B3 in the area of the nucleus raphemagnus and adjacent
ventrolateral reticular formation were shown to give rise to
large numbers of descending 5-HT axons. They traveled all the
way down to the sacral cord in the lateral and anterior funiculi,
sending off collaterals to the dorsal, lateral and ventral horns
of the cervical, thoracic, lumbar and sacral cord.
In 1964, Andén et al. (1964a,b) had obtained evidence that
the spinal 5-HT terminals participated in the modulation of
spinal cord reflexes with liberation of 5-HT, causing a marked
enhancement of extensor reflex activity. This model proved of
substantial interest since it made it possible to discover in
1968 that hallucinogens of the indolalkylamine type like d-LSD
can act as postjunctional 5-HT receptor agonists at certain 5-
HT receptor subtypes in the forebrain, which may substan-
tially contribute to their hallucinogenic properties (Andén et
al., 1968, 1971; Fuxe et al., 1976). These observations, together
with demonstrations of reductions of 5-HT turnover by thehallucinogens, led to the discovery of the molecular mechan-
ism of action of d-LSD and related hallucinogens. In addition,
recent work using single unit responses of 5-HT medullary
raphe neurons has shown that the descending bulbo-spinal 5-
HT neurons are primarily involved in motor control (Martin-
Cora et al., 2005).3. The 5-HT raphe–forebrain neuron systems
and depression
In 1967, it was possible to demonstrate with the Falck–Hillarp
technique the existence of a plasma membrane uptake-
concentration mechanism for 5-HT in the 5-HT neurons with
intraventricular injections of 5-HT (Fuxe and Ungerstedt, 1967,
1968). The next year, it was shown by the Carlsson–Fuxe–
Ungerstedt teams that the classical antidepressant drug
imipramine could block this uptake mechanism (Carlsson et
al., 1968). The same was shown to be true also for other
antidepressants (Carlsson et al., 1969a,b). Overall, two groups
of antidepressants could be distinguished, one which prefer-
entially blocked the 5-HT uptake mechanism and one which
preferentially blocked the NA uptake mechanism. This dis-
covery led to the development of new antidepressants based
on their selective ability to block the 5-HT uptake mechanism,
the so-called selective serotonin reuptake inhibitors (SSRI) that
introduced a new era in antidepressant therapy with the
success of fluoxetine. These novel antidepressants produce a
therapeutic action with chronic drug administration, probably
when the inhibitory 5-HT1A autoreceptors in the raphe cell
bodies have become desensitized with a restoration of their
firing rate, by enhancing 5-HTneurotransmission in the limbic
and prefrontal 5-HT terminal networks. These results indi-
cated a dysfunction of the ascending 5-HT neuron systems to
the forebrain in depressive disorders, with antidepressants
increasing the transmission and restoring function of these 5-
HT neurons resulting in mood elevation and rescue from
depression. For further historical aspects, see (Fuxe andAgnati
(2006). In view of the sleep disturbances present in depression,
it should be noted that, in this period, the global 5-HT
innervation was shown to also play a role in the maintenance
of slow wave sleep 2 (Jouvet, 1972) which was subsequently
supported in work on sleep using selective lesions of the
ascending 5-HT pathways with the neurotoxin 5,7-dihydrox-
ytryptamine (Kiianmaa and Fuxe, 1977).
The uptake-concentration mechanism for 5-HT, as pre-
viously found for CA, is present in the plasmamembraneof the
entire neuron including cell bodies, dendrites, axons andnerve
terminals, as shown with the Falck–Hillarp technique, leading
to probable increases in extracellular 5-HT after 5-HT uptake
blockade by antidepressants close to all parts of the 5-HT
neuron (Carlsson et al., 1968). These observations opened up
the possibility that monoamines may operate also via diffu-
sion in the ECS andnot only via synapses, as subsequently also
strongly indicated in the work of Descarries et al. (1975). Using
the Falck–Hillarp technique, microinjections of monoamines
or application of monoamine substance into the caudate
putamen demonstrated a spread of monoamines in the
striatum, with the development of concentration gradients
from the site of injection (Routtenberg et al., 1968; Ungerstedt
27B R A I N R E S E A R C H R E V I E W S 5 5 ( 2 0 0 7 ) 1 7 – 5 4et al., 1969). These results again indicated that monoamines
can in fact diffuse in the brain tissue. Taken together, this early
work gave experimental support to the theory of Agnati and
Fuxe and colleagues in 1986 that there exists another mode of
communication in the brain besides wiring transmission,
namely volume transmission (see below).
Today, neurobiological basic research as well as clinical
studies have further established that the 5-HT and also the NA
neuron systems are involved in the etiology and therapy of
affective disorders (see Charney, 1998). Thus, the current
pharmacotherapy is based on the discovery of the enhance-
ment of serotonergic and/or noradrenergic neurotransmission
by either inhibiting the intracellular degradation of the
monoamines with monoamine oxidase inhibitors or blocking
their reuptake back into the 5-HT and/or NA nerve terminal by
selective serotonin/norepinephrine reuptake inhibitors, or
tricyclic antidepressants (see Fuxe et al., 1983d; Duman et
al., 1997; Skolnick, 1999; Nestler et al., 2002; Manji et al., 2001;
Nemeroff, 1998), that in turn lead to an increase of extra-
cellularmonoamines (Iversen, 2000; Taylor et al., 2005; Schloss
and Henn, 2004).
The therapeutic action of antidepressant drugs is of proven
effectiveness, but the mechanisms underlying their effect are
still unclear. It is known that, although biochemical changes
produced by antidepressant drugs occur within hours of
administration, therapeutic effects become evident only
after a latency of about 2–3 weeks, suggesting that adaptive
processes induced via activation of patterns of 5-HT and NA
receptor subtypes, including the regulation of specific genes,
are necessary for the long-term effects of these drugs (Coyle
and Duman, 2003; Nestler et al., 2002). Therefore, after the
previously dominating interest in the effects of antidepres-
sants on extracellular neurotransmitter levels in the brain, the
focus of research into antidepressant drug action has over
recent years shifted towards their gradually developing effects
on intraneuronal signal transduction and cellular plasticity
(Manji et al., 2001; Coyle and Duman, 2003). Several data
suggest that antidepressants facilitate activity-dependent
selection of functional synaptic connections in the brain,
and through their neurotrophic effects improve information
processing within neuronal networks compromised in mood
disorders (D'Sa andDuman, 2002). According to a current view,
antidepressants induce processes of neuroplasticity that lead
to a reorganization of central neural networks thus and
thereby generating their therapeutic effects (Kempermann
and Kronenberg, 2003; Nestler et al., 2002; Duman, 2002).
3.1. Neurotrophic factors
Increasing evidence suggests that antidepressant drugs via
actions on the 5-HT and NA neurons may exert their
therapeutic activity, at least in part, through the enhancement
of neurotrophic factor expression and function (Nibuya et al.,
1995; Saarelainen et al., 2003; Duman, 2002). In this context,
several lines of converging evidence suggest that brain derived
neurotrophic factor (BDNF) and its receptor tyrosine kinase
trkB play a central role in the mechanism of antidepressant
action, including electroconvulsive shock treatment (Nestler
et al., 2002; D'Sa and Duman, 2002; Saarelainen et al., 2003;
Shirayama et al., 2002). Recently, an involvement of thefibroblast growth factors (FGFs) has been proposed in mood
disorders (Turner et al., 2006). Antidepressant drugs and
chronic electroconvulsive shock treatment may increase the
expression of fibroblast growth factor-2 (FGF-2) in frontal
cortices and hippocampus (Mallei et al., 2002; Maragnoli et al.,
2004), suggesting that potentially also the FGF-2 expression
could mediate the antidepressant effects, in line with these
results chronic antidepressant treatment increases neurogen-
esis in adult rat hippocampus (Duman et al., 2001) and
recently evidence has been provided that increased neurogen-
esis might play a role in the mechanism of antidepressant
drug action (Santarelli et al., 2003). Depression is associated
with reduced cortical thickness and neuronal size (Rajkowska
et al., 1999) and may even be caused by cortical neuronal
atrophy with the accompanying loss of neuronal communica-
tion in prefrontal cortex.
3.2. Intramembrane receptor–receptor interactions among
GPCRs
5-HT and NA receptor subtypes may not modulate neuro-
trophism alone, but may do so by being part of heteromeric
receptor complexes (receptor mosaics) with other GPCRs.
Within the early 1980s, indications were obtained for the exis-
tence of intramembrane receptor–receptor interactions among
GPCRs (Agnati et al., 1980, 1983; Fuxe et al., 1981, 1983c). Of
special interest for depression was the discovery of reciprocal
galanin receptor galR/5-HT1A receptor–receptor interactions
in the plasma membranes of ascending 5-HT neuron systems
(Fuxe et al., 1988c, 1991; see Hedlund and Fuxe, 1996). This re-
search, using also animal models of depression (Bellido et al.,
2002), led to the proposal that galanin receptor antagonists
represent novel antidepressant drugs by increasing 5-HT
neurotransmission by actions at the cell body/dendritic level,
leading to increased firing of the 5-HT neurons and by
enhancing postjunctional 5-HT1A mediated signaling in the
limbic system by blockade of the antagonistic galR/5-HT1A
receptor interactions in postulated galR/5-HT1A heteromers
(Fuxe et al., 2007).
3.3. Transactivation of receptor tyrosine kinases
following G-protein-coupled receptor (GPCR) activation
via GPCR/RTK receptor interactions
Receptor tyrosine kinases are a family of membrane-spanning
receptors in mammals that mediate the transmembrane
signaling from ligands that include the majority of growth
factor receptors, such as platelet-derived growth factor (PDGF),
epidermal growth factor (EGF), neurotrophins (e.g., BDNF) and
FGFs (Hubbard, 2004). In each case, dimerization and tyrosine
phosphorylation of receptor tyrosine kinases occur, and this
phosphorylation serves as docking sites of adaptor proteins
that lead to the activation of intracellular signaling pathways
(Luttrell et al., 1997; Hackel et al., 1999) such as Ras-mitogen-
activated protein kinase (MAPK) cascade (Patapoutian and
Reichardt, 2001).
There is a new awareness that receptor tyrosine kinase
(RTK) and G-protein-coupled receptor (GPCR) possess the
capacity for transactivation not only via GPCR induced release
of neurotrophic factors, but also during signal initiation and
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using receptor tyrosine kinase themselves as signaling plat-
forms via direct receptor–receptor interactions (Fig. 7). Thus,
over the past decade many examples of transactivation of
mitogenic growth factor receptors in response to GPCR
signaling have recently been reported indicating that there
are alternative modes of activating receptor tyrosine kinases
in the absence of neurotrophic factor binding at the cell
surface (Luttrell et al., 1999; Marinissen and Gutkind, 2001; Lee
et al., 2002a,b; Luttrell, 2002; Lowes et al., 2002).
The receptors for epidermal growth factor, platelet-derived
growth factor, insulin-like growth factor-1, FGFs and neuro-
trophins can thus be transactivated in response to GPCR
activation in the absence of neurotrophic factor binding at the
cell surface via direct (heteromeric receptor complexes) and/or
indirect GPCR/RTK receptor interactions (Kang and Schuman,
1995; Luttrell et al., 1999; Lee and Chao, 2001; Lee et al., 2002a,b;
Kotecha et al., 2002; Ferguson, 2003; Rauch et al., 2004; Shah
and Catt, 2004; Rajagopal et al., 2004; Berghuis et al., 2005). This
RTK transactivation via GPCR–RTK receptor interactions (Fig.
7) can lead to effects on cell proliferation, differentiation and
synaptic plasticity and may play crucial roles in the induction
of enduring change in the nervous system trophism via VT
signals operating through GPCR.
Thus, there appears to exist a general mechanism of
receptor–receptor interactions between these two receptor
systems, but themolecularmechanisms bywhich a GPCRmay
directly and indirectly interact with and activate receptorFig. 7 – Illustration of GPCR–tyrosine receptor kinase (TRK)
receptor interactions as a mechanism for GPCR
transactivation of TRK receptors without neurotrophic factor
binding to TRK. Direct receptor–receptor interactions may
develop in the cell surface membrane or indirect
receptor–receptor interactions may take place in the
intracellular signaling cascades formed by vertical molecular
networks reaching into the nucleus, involving e.g., the
Raf–MEK–ERK cascade. The GPCR is shown as a receptor
mosaic (Rec Mosaic), in this case a high-order homomer.tyrosine kinases in the absence of neurotrophic factor binding
are not fully understood. The research reviewed above is of
special interest to this article since it serves to demonstrate
how VT transmitters via activation of GPCRs can strongly
modulate trophism via the GPCR–RTK receptor interactions
(Fig. 7).
3.4. Serotonin receptor subtypes and the possible
transactivation of the FGF-2/FGFR1 neurotrophic system
FGFR1 is constitutively expressed in neurons of target brain
regions involved in depression, including the raphe nuclei
(Belluardo et al., 1997). FGF-2, a trophic factor binding to
FGFR1, is widely expressed in the brain both in astrocytes and
neurons (Fuxe et al., 1996) and is co-expressed in the perikarya
of practically all raphe 5-HT nerve cells (Chadi et al., 1993; Fuxe
et al., 1996). Furthermore, antidepressant drugs and chronic
electroconvulsive shock treatment increase the expression of
FGF-2 in frontal cortices and hippocampus (Follesa et al., 1994;
Mallei et al., 2002; Gwinn et al., 2002; Maragnoli et al., 2004),
suggesting a beneficial role of FGF-2 in mood disorders.
Compelling evidence shows that the alleviation of depres-
sion caused by serotonin selective reuptake inhibitors is
produced by increasing the availability of serotonin at the
postjunctional 5-HT receptor subtypes involving a down-
regulation of the 5-HT1A autoreceptors in the raphe regions
(Artigas et al., 1996; Albert et al., 1996). It seems possible that a
certain pattern of activity at different 5-HT receptor subtypes
of the seven 5-HT receptor families identified (Hoyer et al.,
2002) is necessary to counteract the depression since certain
antidepressant drugs can even block certain 5-HT2 like
receptors (Fuxe et al., 1977c; Ogren et al., 1979; Peroutka and
Snyder, 1979, 1980).
Taken together, these findings open up the possibility that
antidepressant drugs by the indirect stimulation of the 5-HT
receptor subtypes located on the mesencephalic 5-HT raphe
cells, mainly of the 5-HT1 type, can cause an activation of the
FGF-2/FGFR1 mechanism in these 5-HT nerve cells. Such an
activation may involve also a 5-HT receptor subtype mediated
transactivation of the FGFR1. Events of this type may improve
5-HT neurotrophism with regeneration of 5-HT terminal
systems lost during depression and result in improved 5-HT
communication, explaining the crucial impact of activation of
certain 5-HT receptor subtypes in the 5-HT nerve cells to
alleviate depression. In line with this hypothesis, extended
treatment with a selective 5-HT uptake blocker zimelidine
causes increases in 5-HT immunofluorescence in the dorsal
raphe (Fuxe et al., 1983a). It is of substantial interest that
inescapable shock causes a widespread c-fos activation of the
5-HT nerve cells of the entire raphe system of the lower brain
stem (Takase et al., 2004). This may represent a compensatory
mechanism to cause upregulation of the neurotrophic
mechanism in the 5-HT nerve cells to help their survival
and function to counteract depression development.
As a consequence of increased activity in the ascending 5-
HT pathways and increased 5-HT release in the target regions
after prolonged treatment with antidepressant drugs, the
increased stimulation of certain postjunctional 5-HT receptor
subtypes may also cause activation of neurotrophic factor
systems in the target regions like the limbic system. It is
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activated and a transactivation of the FGFR1 may occur. In
fact, previous studies have indicated that 5-HT can exert
neuroprotective effects on a variety of neurons from the
central nervous system (Lesch, 2001). Azmitia and colleagues
have emphasized the importance of astroglial 5-HT1A recep-
tors in the neurotrophic actions of neuronal 5-HT (Whitaker-
Azmitia et al., 1990; Azmitia and Whitaker-Azmitia, 1991;
Azmitia, 2001), and 5-HT appears to function in a cooperative
manner with neurotrophins when regulating survival and
neuronal plasticity (Galter and Unsicker, 1999; Mattson et al.,
2004). Therefore, neurotrophins are considered as mediators
of antidepressant effects (Castren, 2004). A deficiency in
monoamines like 5-HT, which occurs in depression, would
probably result in reduced cellular plasticity as a consequence
of decreased expression of trophic factors in different brain
structures (Manji et al., 2003). Serotonin receptors have also
been involved in transactivation of the receptor tyrosine
kinase ApTrk linked to biochemical events leading to long-
term facilitation in aplysia (Ormond et al., 2004) and in
transactivation of the epidermal growth factor receptor
(Grewal et al., 2001; Luttrell, 2002).
In conclusion, the neurotrophic system FGF-2/FGFR1 may
be a good candidate to mediate antidepressant induced
improvement in 5-HT neuronal communication and neuro-
trophismwith regeneration of connections lost during depres-
sion (Kitayama et al., 2004). Receptor tyrosine kinase
transactivation in response to antidepressant drug treatment
is postulated to take place via a new receptor–receptor
mechanism between serotonin receptor subtypes and FGFR1
activation. Novel research in this field may increase our
understanding of the mechanisms of antidepressant drug
action and lead to the development of new strategies for
treatment of depression. For the first time, it seems possible to
identify the molecular neurotrophic mechanisms in the 5-HT
nerve cells the activation of which causes a relief from
depression. Future work based on the present hypothesis
may identify if this neurotrophic system (FGF-2/FGFR1) can
mediate improvement in 5-HT neuronal communication and
neurotrophism. It may in fact reveal the existence of receptor
tyrosine kinase transactivation in response to antidepressant
drug treatment, by demonstration of a new receptor–receptor
interaction mechanism between serotonin receptor subtypes
and FGFR1 activation. These expected results will increase our
understanding of the mechanisms of antidepressant drug
action and lead to the development of new strategies for
treatment of depression.4. Two modes of brain communication:
wiring and volume transmission
4.1. The foundations leading up to the 1986 proposal of
wiring and volume transmission
Interneuronal communication is a basic feature of the CNS
and is defined as the transmission of signals from one neuron
to the next in a neuronal network via a specialized contact
between two neurons. This contact has been called the sy-
napse and was based on the neuron doctrine of Cajal. Synaptictransmission is the prototype of wiring transmission and has
been the main foundation of neuroscience as we know it. The
chemical synapse (see Fig. 1) is a specialized presynaptic nerve
ending rich in transmitter-containing synaptic vesicles, con-
tacting a specialized plasma membrane of the postsynaptic
neuron. Synaptic transmission is therefore a point-to-point
transmission between neurons. The synaptic organization of
the neuronal networks of the brain was first proposed by Cajal
using the Golgi technique (1906) and subsequently by Sher-
rington (1947) using electrophysiological techniques. Today,
through electron microscopy work, the discontinuity gap
between the pre- and postsynaptic elements is known to
mainly range from 30 to 50 nm with a synaptic delay of 0.3 to
5 ms or longer. It should be noted that Golgi held an opposite
view, namely the existence of a diffuse neuronal network
enabling interneuronal communication (see Jacobson, 1993).
In the 1970s and 1980s, the functional assumption of a
diffuse mode of interneuronal communication affecting the
activity of entire brain regions was gaining support by the
observations made on monoaminergic neurons as discussed
above (see also Geffen et al., 1976) and on peptidergic neurons
(De Wied and Jolles, 1982; Bloom and Segal, 1980; Burbach,
1982; Fuxe et al., 1977b, 1980b,c, 1986; Agnati et al., 1986b).
Phylogenetic studies also pointed to the appearance of a
diffuse interneuronal communication in primitive nervous
systems (Nieuwenhuys, 1985). Neurons arose during evolution
from cells with elongated processes secreting informational
molecules into the extracellular fluid (ECF) to reach close-by
target cells. Thus, synaptic transmission was not involved in
the beginning of the development of the nervous system. The
diffuse type of neuronal organization was easily detected in
lower organisms (Haskins et al., 1981; Mayeri et al., 1985). As
an example, bag cell axons in the abdominal ganglia of the
mollusc aplysia only reach the surrounding connective tissue
of the ganglia. Thus, the activity of the ganglionic cells is
controlled by peptides, released from the far away axons,
which diffuse into the ganglion to reach the receptors on the
ganglionic cells. Thus, communication via the ECF appears to
be a common mode within the invertebrate nervous system
(see, e.g., Branton et al., 1978). It has also been shown in
amphibian autonomic ganglia that LHRH released from
preganglionic fibers can affect excitability and calcium influx
of groups of neurons without direct innervations by LHRH
containing nerve terminals (Jan and Jan, 1982, 1983). Thus, this
mode of communication may also be used in the mammalian
nervous system.
Thus, there was a need for a new classification for inter-
neuronal communication in the brain since the classical
criteria stated for synaptic transmission could not be main-
tained. Ultrastructural findings in the mammalian nervous
system had a special value in this regard showing e.g., that
large core vesicles which are especially enriched in neuropep-
tides can be located outside synapses and preferentially
associated with non-synaptic membranes (Zhu et al., 1986).
Another important ultrastructural observation was the find-
ings of small vesicles in high densities in monoamine
varicosities lacking synaptic specializations, indicating the
existence of both non-junctional and junctional monoamine
varicosities releasing monoamines in various brain regions
(Descarries et al., 1975, 1977; Beaudet and Descarries, 1978). A
Table 1 – Features of volume transmission
Type of signals
Chemical: neurotransmitters, neuromodulators, growth
factors, ions, gases
Physical: electrotonic currents, pressure gradients,
temperature gradients
Pathways
ECS, isotropic and anisotropic migration
CSF, vector-assisted migration
Energy gradients for signal migration





Receptors, enzymes, ion channels
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over the cerebral cortex (Descarries et al., 1975, 1977) and in the
external layer of the median eminence (see Buma and
Nieuwenhuys, 1988), where various types of local circuits had
been postulated to form different types of medianosomes
(Fuxe et al., 1980a, 1985). In line with these results, Mobley and
Greengard (1985) demonstrated widespread effects of nora-
drenaline on the metabolism of terminals in the cerebral
cortex since NA release via β-adrenergic receptors could
increase synapsin1 phosphorylation present in almost all
terminals of the cerebral cortex. Early indications of the
existence of CA diffusion in the brain and their release into
the extracellular fluid using the Falck–Hillarp technique also
strongly supported the theory of a widespread mode of
communication besides synaptic transmission (Routtenberg
et al., 1968; Fuxe and Ungerstedt, 1968, 1970; Ungerstedt et al.,
1969; Butcher et al., 1970).
Of high relevance for introducing a new classification of
intercellular communication was also the potential existence
of chemical networks of peptides in the extracellular fluid,
through formation of biologically active peptide fragments via
extracellular peptidases (De Wied and Jolles, 1982; Agnati et
al., 1983; Fuxe et al., 1980b, 1986). The evidence in the 1986
study (Agnati et al., 1986a) also indicated that the opioid
peptides mainly communicated via VT, which was supported
by the apparent lack of reuptake mechanisms in peptide
neurons. Thus, once released, peptides would diffuse from the
site of release until degraded by peptidases or converted into
active fragments.
A number of proposals, although different from each other,
were therefore made in this period to indicate that other
modes of interneuronal communication may operate in the
brain besides the synaptic transmission (Guillemin, 1978;
Nicholson and Phillips, 1981; Cuello, 1983; Schmitt, 1984;
Vizi, 1984). These alternative ways of interneuronal commu-
nication were called non-synaptic transmission between neu-
rons (Vizi, 1984), non-classical neuronal communication (Cuello,
1983) or parasynaptic transmission operating in parallel with the
synaptic system (Schmitt, 1984). However, such terms over-
looked the importance of neuron–glia and glia–glia commu-
nication in the CNS and that point-to-point communication in
the CNS involves also gap junctions andmembrane juxtaposi-
tions (Bennett and Goodenough, 1978; see Shepherd, 1991).
Guillemin pointed out that nerve cells also behave as
endocrine cells for local actions (Guillemin, 1978) and Vizi
focused on the existence of cross-talk between close-by axon
terminals via the ECF (Vizi, 1984).
In 1986, Agnati and Fuxe and their team made the
important observation that the distribution pattern of μ-opioid
receptors in the brain, as studied with quantitative receptor
autoradiography, failed to correlate with the distribution
pattern of enkephalin and β-endorphin immunoreactive ter-
minal networks, as studied with semiquantitative immuno-
cytochemistry and image analysis (Agnati et al., 1986a).
Transmitter–receptor mismatches discovered by receptor
autoradiography and transmitter immunohistochemistry
had previously been observed by Kuhar et al. (1985). Taken
together, the above observations were very inspiring to Agnati
and Fuxe since in their mind they provided impressive
evidence that transmitters after release from their terminalsmay reach their unique receptors via diffusion for short and
long distances in the extracellular fluid of the brain. Using a
correlation analysis, their results obtained were also not very
dependent on the sensitivity of the chemical anatomical
techniques used. Based on these and previous observations
(see above), they therefore proposed in their 1986 paper (Agnati
et al., 1986a) that there exist two main types of intercellular
communication in the CNS: wiring and volume transmission
(WT and VT), see Tables 1–3.
WT was defined by the presence of physically distinct
communication channels within the neuronal circuits. Thus,
communication occurs as in a “wire”, which represents
relatively fixed structures well suited for the rapid and safe
conduction of the action potentials. The prototype for WTwas
the classical synaptic transmission with point-to-point trans-
fer of chemical signals in the synaptic gap, representing a
discrete transmission with low to moderate divergency and
plasticity (see Tables 1–3). VT was defined as the intercellular
communications between nerve cells, and/or glial cells
(including endothelial and ependymal cells), characterized
by diffusion of chemical signals and flow of ionic currents in
the fluid of the extracellular space, the latter representing
electrotonic signals (Agnati et al., 1986a; Fuxe et al., 1988a;
Agnati and Fuxe, 2000). The flow of extracellular ionic current
generated by nerve cells has been called volume conduction
(Martin, 1985). This termmade it reasonable to us to introduce
the term volume transmission to describe the general phenom-
enon of signal transfer in the extracellular space, including the
diffusion of chemical signals like transmitters andmodulators
in the extracellular fluid (Fig. 8, Table 1). In fact, the neuronal–
glial networks of the CNS are immersed in the volume of the
extracellular space rich in chemical signals modulating their
activity. Thus, information flows in the extracellular space.
Important work in the field of volume conduction was early
made by Nicholson (1979), providing evidence that the brain
cell microenvironment is a communication channel for ions,
and demonstrated that ion diffusion can be modified by the
properties of the extracellular environment (Nicholson and
Phillips, 1981). Indications were also obtained that neuroactive
substances may migrate along microvessels in paravascular
channels (Brightman, 1965; Rennels et al., 1985).
The Agnati–Fuxe team (Agnati et al., 1986a; see also Agnati
et al., this issue) characterized VT as a widespread (diffuse),
Table 2 – Differential properties of wiring transmission (WT) and volume transmission (VT) communication channels
WT VT
Type of signal Ions (electrical synapses) and
neurotransmitters (e.g., amino acids)
Ions (e.g., K+, H+), neurotransmitters, growth factors,
gases and neuromodulators (e.g., monoamines,
neuropeptides, NO, adenosine, neurosteroids)
Concentration of chemical signal at receiver Usually high (μM) Usually low (nM)
Receiver affinity for the chemical signal Usually low (high nM to μM) Usually high (pM to low nM)
Transmission codea Rate and temporal code Rate code
Transmission delay Low (ms) High (s to min)
a Rate code models hold that changes in the firing rate signal an event (a train of impulses) which in the VT can be equated to the arrival of the
VT signal at the receptor at suprathreshold concentration. The average rate of impulses in the train codes the strength of the stimulus which in
the VT can be equated to the VT signal concentration at the target receptor level. Temporal codes hold that information is encoded by the precise
occurrence of spikes over time. This constraint makes it unlikely that this type of code is used in VT.
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in the extracellular fluid of the CNS, including also the
cerebrospinal fluid with a high to very high divergence and
plasticity. The VT communication was described to consist of
migration of transmitters, modulators, trophic factors and
ions from the source cells to the receptor containing target
cells, along extracellular channels shaped by the packing of
the glial and neuronal cell mass and by the vascular
architecture (Fig. 8, Tables 1–3). VT was proposed to be
preferentially involved in long-term actions and a holistic
elaboration of information, with long-lasting modulation of
large neuronal–glial cellular networks for information hand-
ling and trophism. Conversely,WTwas preferentially involved
in elementary elaboration and short-term actions. The
essence of the pioneering theory introduced in 1986 was that
the operation of the neuronal–glial networks of the brain
builds on two complementary modes of communication for
information handling, wiring transmission and volume trans-
mission, interacting with each other (Fig. 8, Tables 1–3) (Agnati
et al., 1986a; see also Agnati et al., this issue). With the
acceptance of this theory the Golgi–Cajal conflict on brain
communication has come to an end, and their opposing views
on brain communication can now become united in this
theory on wiring and volume transmission as the two major
modes of communication in the brain.
4.2. Further experimental evidence for the existence
of volume transmission
4.2.1. Failure of storage of transmitters/modulators in
synaptic vesicles
Nerve cells are not the only sources of transmitters and
modulators since it has been found that neuroactive com-Table 3 – Differential properties of WT and VT circuits
WT VT
Cell composition Mainly between
neurons and
between astrocytes
Any cell type in
the CNS
Divergence Low Potentially high
Type of connectivity Preferentially serial Preferentially parallel
Space filling High Low
Time scale ms to s s to min
Biological effect Typically phasic Typically tonicpounds can be stored and released also from glial cells (see
Murphy et al., 1993; Martin, 1992; Nedergaard, 1994). It has also
been shown that the gas NOmay function as an interneuronal
signal in the brain, being synthesized on demand from its
precursor L-arginine by NO synthase and freely diffusing out
from the source cell (see Garthwaite et al., 1989; Gally et al.,
1990; Snyder and Bredt, 1991; Murphy et al., 1993). The same
appears to be true also for CO and H2S, which may act as
gaseous transmitters (Wang, 2002). Furthermore, an impor-
tant modulator of brain function like prostaglandin D2 is
formed from prostaglandin D, which is mainly located in
leptomeninges, choroid plexus and oligodendrocytes (Urade et
al., 1993; Hayaishi, 1991). Thus, it seems as if all non-neuronal
cells of the CNS can give rise to VT signals.
4.2.2. Lack of calcium-dependent vesicular release of
transmitters
Calcium-independent non-vesicular release of transmitters
may occur e.g., for GABA, glutamate, glycine andmonoamines
via a reversal of the uptake-transporter mechanisms, which
thus can operate in reverse to transport the transmitters out of
the cell into the extracellular fluid (Amara and Kuhar, 1993;
Attwell et al., 1993; Hansra et al., 2004). Also cystin/glutamate
exchange serves as a source of extracellular glutamate to act
as a VT signal (Baker et al., 2001). For a review on the classical
synaptic transmitters glutamate and GABA as VT signals, see
Del Arco et al. (2003).
4.2.3. Release of transmitters not in strict contiguity with
postsynaptic membranes
After 1986, the ultrastructural analysis in several studies
strengthened the evidence that large dense core vesicles rich
in neuropeptides were preferentially associated with non-
synaptic membranes (Matteoli et al., 1988; Sossin et al., 1989;
Thureson-Klein and Klein, 1990; Barinaga, 1993; see Koob et
al., 1990). Thus, the release of peptides commonly occurs
extrasynaptically (Golding, 1994). However, transmitters also
become VT signals via a spillover from leaking (open)
synapses (Fuxe and Agnati, 1991a; Zoli and Agnati, 1996;
Rusakov et al., 1999). The elegant work showing the high
incidence of non-junctional monoamine varicosities has
continued to also include the demonstration of non-junc-
tional DA varicosities in the neostriatum (see Descarries et al.,
1991, 1996; Descarries and Mechawar, 2000). Ultrastructural
evidence for a particularly high frequency of non-junctional
Fig. 8 – Some basic features of the wiring and volume transmission (WT and VT) are illustrated in terms of space filling and
safety of transmission.
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systems (Umbriaco et al., 1994; Descarries and Mechawar,
2000; Descarries, 1998). Thus, like in the monoamine systems,
VT appears to be the major mode of operation in the cortical
acetylcholine nerve terminal systems and a globalmodulation
of large cell populations becomes possible. Descarries and
colleagues (see Descarries and Mechawar, 2000) refer to
volume transmission as a “diffuse transmission”, which is
part of the characteristics of volume transmission (Agnati et
al., 2000a; Fuxe and Agnati, 1991a; Agnati and Fuxe, 2000). It
should be noted that the isoform of acetylcholinesterase
existing in the central cholinergic systems is not as effective in
breaking down acetylcholine as in the neuromuscular choli-
nergic synapses,making it possible to have awidespread VT in
operation. The existence of a high frequency of non-junctional
varicosities in the dorsal horn was further documented (Ridet
et al., 1992). The existence of non-junctional varicosities in the
CNS implies that VT also plays an important role in the local
circuits of the brain and especially in the cerebral cortex, the
dorsal horn and the external layer of the median eminence. It
should be noted however that, in the ventral horn, the
monoamine terminal varicosities mainly form synapses
(Ridet et al., 1992), which is in line with early work of Carlsson
et al. (1964) and Fuxe (1965a,b) showing CA terminals with
green fluorescent varicosities outlining the cell bodies and
dendrites.4.2.4. Location of transmitter receptors outside the
postsynaptic density
The ultrastructural analysis based on transmitter and receptor
immunocytochemistry has repeatedly demonstrated short
distance transmitter/receptor mismatches for the peptide
and classical transmitters with the receptor labeling outside
synapses (Dana et al., 1989; Pasquini et al., 1992; Levey et al.,
1993; Liu et al., 1994; Sesack et al., 1994; Aoki, 1992; Aoki and
Pickel, 1992; Yung et al., 1995; Caillé et al., 1996; Aoki et al.,
1998; Azmitia andWhitaker-Azmitia, 1991; Azmitia et al., 1996;
Boudin et al., 1998; Baude and Shigemoto, 1998; Dournaud et
al., 1998). Extrasynaptic location of receptors has been
observed mainly for G-protein-coupled receptors, but also for
ion channel linked receptors (Aoki et al., 1994). Both these
types of receptors have been observed on astroglia which
generally lack synapses, giving evidence for neuron–glia
communication via VT (see Kimelberg, 1988; Stone andAriano,
1989; Murphy and Pearce, 1987; Sontheimer et al., 1988; Barres
et al., 1990; Aoki, 1992; Azmitia and Whitaker-Azmitia, 1991).
These studies emphasize the impact of VT in the information
handling of the local circuits.
As an example, dual immunolabeling of β-adrenergic
receptors and CA nerve terminal networks in the cerebral
cortex using electron microscopic immunocytochemistry
showed membrane contacts between CA nerve terminals
rich in vesicles and β-adrenergic immunoreactive (IR) astro-
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(Aoki, 1992). It was of interest that these β-adrenergic receptor
IR astrocytes also surrounded asymmetric axo-spinous
synapses, where the astroglia β-adrenergic receptors may
modulate e.g., glutamate spillover by modulating the activity
of the glial glutamate transporters and/or the permeability of
the astroglial gap junctions, and thus the sphere of astroglia
activation (see Aoki, 1992). In another study with similar
techniques, Aoki and colleagues also demonstrated that
prefrontal NA terminal networks can interact via VT with
astroglia, dendritic shafts and axon terminals through their
α2-adrenergic receptors as well as in synaptic interactions
through α2-adrenergic receptors located in postsynaptic
membranes at spines of pyramidal cells (Aoki et al., 1998).
Another example from the monoamine neurons is the
analysis of the cellular localization of 5-HT1A receptors in the
brain by Azmitia et al. (1996). Using immunocytochemistry on
brain sections, 5-HT1A IR was shown to be located in both
neurons and cell bodies and processes of astroglia (Azmitia et
al., 1996). 5-HT neurons may therefore via VT modulate the
astroglia function through their 5-HT1A receptors, and these
astroglia 5-HT1A receptors are known to release serotonin
growth factors like protein S-100 (Whitaker-Azmitia et al.,
1990). In this way, via 5-HT1Amediated VT involving astroglia,
5-HT may induce its own trophic support.
Continued structural analysis, using double immunolabel-
ing receptor and immunohistochemistry or transmitter histo-
chemistry together with receptor autoradiography, has given
evidence for the frequent existence of long-distance transmit-
ter/receptor mismatches (topological mismatches) in the
monoamine and peptide systems (see Herkenham, 1987; Fuxe
et al., 1988b, 2003b; Zoli et al., 1989; Bunnemann et al., 1991;
Ferré et al., 1996; Jansson et al., 1998, 1999, 2001, 2002; Schwartz
et al., 1998; Caberlotto et al., 1998; Fuxe et al., 2005; Jacobsen et
al., 2006). Such observations strongly indicate the existence of
long-distance VT in the brain. Although Bowers in 1994
suggested that mismatch high-affinity receptors represent
superfluous receptors, the fact that mismatch and match
receptors have similar binding characteristics suggests that
themismatch receptors in fact are reached by their transmitter.
The distinct architecture of the transmitter/receptor mis-
match compartments also favors their involvement in VT.
This is particularly true for the dopamine D1 and D3 receptor
mismatch compartments in nerve cell populations of the
nucleus accumbens shell, the intercalated islands of the
amygdala and the islands of Calleja surrounded by DA nerve
terminal plexa (Diaz et al., 1995; Jansson et al., 1999; Fuxe et al.,
2003b, 2005). It now seems clear that transmitter–receptor
mismatch is the architecture of volume transmission. It
should be noted that the dopamine D4 IR nerve cells and
dendrites of the rat cerebral cortex are mainly intermingled
with NA nerve terminals, indicating that the source of
diffusing DA may be the NA terminals from which also the
precursor DAmay be released (Rivera, Fuxe et al., unpublished
data). The diffusion of DA is favored versus the diffusion of NA
since DA unlike NA is not a substrate for the NA transporter.
Studies on the vertebrate retina have given one of themost
clear-cut examples of transmitter–receptor mismatches in DA
transmission. The amacrine and/or the inner plexiform DA
nerve cells are located in the inner nuclear layer, with theirterminal branches mainly innervating the inner plexiform
layer and with very few radial branches into the outer
plexiform layer which contain a high density of dopamine
D1 and D2 receptors. Mismatch DA receptors are also found
within the outer segment of the photoreceptors and in the
ganglionic cell layer (Djamgoz andWagner, 1992;Witkovsky et
al., 1993; Bjelke et al., 1996). These results had inter alia been
obtained by DA D1 and D2 receptor immunocytochemistry in
combination with tyrosine hydroxylase immunocytochemis-
try and by dopamine D1 and D2 receptor autoradiography.
These DA receptors have also been shown to be biologically
active by influencing slow light/dark adaptation in horizontal
cells involving regulation of adenylate cyclase activity. Thus,
DA VT exists in the retina, especially in its outer part.
Spatial uncoupling between sites for signal release and
detection is also true for NO transmission. NO is a rapidly
diffusible signal which easily crosses cell membranes to
activate the cytosolic enzyme guanylate cyclase, resulting in
cGMP formation with modulation of membrane function and
the intracellular phosphorylation/dephosphorylation cas-
cades and thereby gene expression (Garthwaite et al., 1989;
Gally et al., 1990; Snyder and Bredt, 1991). A single source of
the NO signal can thus tune the activity of a set of nerve and
glial cells in the immediate surrounding of the NO source
independently of WT.
4.2.5. Deficits of fast inactivation mechanisms of the
transmitter
Using antibody microprobes, a marked release, spread and
persistence of immunoreactive neurokinin A were found all
over the dorsal horn after noxious cutaneous stimulation by
Duggan et al. (1990). These results provided strong evidence
for long-distance VT in peptide neurons as far as neurokinin A
was concerned. In contrast, substance P (SP) remained in the
substantia gelatinosa where the SP/neurokinin A IR terminals
are concentrated. It seemed likely that the slow degradation of
neurokinin A versus SP was responsible for these differential
effects on neurokinin A (Duggan et al., 1990). This proposal
was elegantly supported by the demonstration that a pepti-
dase inhibitor microinjected into the dorsal horn demon-
strated the spread of immunoreactive SP over the entire dorsal
horn after noxious cutaneous stimulation (Duggan et al.,
1992). It is of special interest that calcitonin-gene related
peptide (CGRP) co-stored with SP in the primary afferents in
the dorsal horn via peptidase inhibition can modulate VT in
the SP primary afferents involved in mediation of pain. Via
such an action, CGRP can increase the intraspinal spread of SP
following peripheral nerve activation (Schaible et al., 1992).
Thus, the ratio of co-stored peptides can be of importance for
their actions through VT. These observations give evidence
that peptides when released from their nerve terminal
varicosities can diffuse in the extracellular fluid for up to
millimeters dependent on their rate of degradation by
extracellular peptidases. Their major mode of communication
appears to be VT, which according to the above findings plays
an important role in nociception in the spinal cord.
These results also show that extracellular enzymes may
have an important role in limiting the diffusion of peptides in
the extracelluar space (ECS) and thus to peptide VT (see also
Jansson et al., 2002). Glial forms of the endoprotease 3.4.24.16
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located for such actions (Vincent et al., 1996). However,
secreted endopeptidases or endoproteases may either termi-
nate or enhance peptide signaling through the formation of
inactive or active fragments, respectively, as suggested e.g., for
galanin (Hedlund et al., 1992, 1994; Hedlund and Fuxe, 1996).
Extracellular enzymes, attached to plasma membranes or
located in the ECS, are also regionally distributed in the brain.
They will therefore produce regionally different chemical
networks of peptides in the ECS, leading to formation of
multiple VT lines with different ratios depending on region.
Therefore, the spreading and function of peptides as VT
signals can be understood in a better way by subdividing them
into presignals, syndromic signals and enzyme modulatory
signals (see above; De Wied and Jolles, 1982; Koob et al., 1990;
Agnati et al., 1986a,b, 2000a; Fuxe et al., 1980b, 1986, 1988a;
Fuxe and Agnati, 1991a,b; Davis and Konings, 1993; Brownlees
and Williams, 1993; Burbach et al., 1981). The presignal is a
peptide released in an inactive form. The syndromic signal is a
large peptide molecule which may be active as such and in
addition under the influence of peptidases to form a set of
active fragments capable of triggering a set of concerted
responses (syndromic response). As examples β-endorphin,
neurotensin, cholecystokinin and neuropeptide Y derived
peptides may be mentioned.
One of the best examples of a long-distance VT signal is β-
endorphin. As already discussed, there was a lack of correla-
tion between the distribution of β-endorphin nerve terminal
plexa versus the μ- and ∂-opioid receptor distribution with
clear-cut transmitter–receptor mismatches in the cerebral
cortex and the striatum having few if any β-endorphin
terminals (Agnati et al., 1986a; Mansour et al., 1986, 1988;
Fuxe et al., 1988a, 2005; Herkenham, 1987; Jansson et al., 2002).
Based on these observations, it was suggested by the Agnati–
Fuxe team that β-endorphin can act as a long-distance VT
signal (Agnati et al., 1986a; see also Herkenham, 1987; Fuxe et
al., 1988a). Based on this work, Duggan and co-workers
(MacMillan et al., 1998) performed experiments with electrical
stimulation of the arcuate β-endorphin IR nerve cell popula-
tion (MacMillan et al., 1998). In these experiments they
observed that β-endorphin IR could be detected in remote
brain areas lacking β-endorphin IR terminals, like the cerebral
cortex, 60–90 min after the initial stimulation of the arcuate
nucleus. These results gave strong indications that β-endor-
phin could migrate for long distances in the extracellular fluid
after its release from β-endorphin IR nerve terminals.
Recently, it was found that β-endorphin microinjected intras-
triatally can be detected in the cerebrospinal fluid with
radioimmunoassay and mass spectrometry with a peak at
30min post-injection (Höistad et al., 2005). The β-endorphin IR
material in the CSF existed mainly as the intact β-endorphin
peptide and immunohistochemically β-endorphin IR
appeared in globus pallidus cell bodies colocated with μ-
opioid receptor IR at the surface membrane (Höistad et al.,
2005). This is in line with previous results indicating inter-
nalization of β-endorphin in paraventricular nerve cell
populations and in tanycytes of the median eminence after
intra-cerebroventricular injection of β-endorphin (Agnati et
al., 1992; Bjelke and Fuxe, 1993). Taken together, the evidence
indicates that β-endorphin canmigrate for long distances as aVT signal via diffusion in the extracellular fluid and flow in the
cerebrospinal fluid. Thus the β-endorphin neurons of the
brain (Bloom et al., 1978) mainly act via VT.
The anti-nociception elicited by electrical stimulation of
the mesencephalic gray (stimulation-produced analgesia) can
be observed only seconds after the stimulation has begun. In
contrast, it may last for hours after the stimulation is
terminated. For example, in humans stimulation induced
analgesia can produce relief from chronic pain that persists up
to 24 h after the stimulation period (Bonica, 1990). The
mechanism has been postulated to be a stimulation evoked
release of a VT signal which reaches its receptor after diffusion
and acts for long periods in view of its slow degradation
(Agnati et al., 1991, 1993). Based on the above discussion, we
postulate that β-endorphin may be an important VT signal in
this phenomenon involving flow in the CSF.
It should be mentioned that also cytokines like inter-
leukin-1β (IL-1β) can be a powerful long-distance VT signal
(see Jansson et al., 2000) mainly of a glial origin (Licinio and
Wong, 1997; Sykova et al., 1998). This is supported by the
presence of soluble extracellular IL-1β receptor antagonist
ligands and decoy receptors (Colotta et al., 1993; Schobitz et
al., 1994), suggesting a strictly regulated IL-1β transmission in
the ECF. Local microinjections of IL-1β into the neostriatum
have given observations that striatal IL-1β exerts local and
distant effects on microglial cells, and distant effects on
paraventricular hypothalamic nerve cells, suggesting that IL-
1β is a VT signal capable of long-distance diffusion and
convection through the extracellular space and cerebrospinal
fluid, acting on IL-1β receptors in the ependymal cells, the
choroid plexus, the meninges and the brain capillaries
(Jansson et al., 2000, submitted for publication). Thus, locally
formed IL-1β in the brain may via VT produce fever responses
(Alheim et al., 1997) and pro-inflammatory events (Andersson
et al., 1992), contributing to increases in blood–brain barrier
permeability and leading to neuroimmune interactions
(Anthony et al., 1997).
4.3. The extracellular space and cerebrospinal fluid
4.3.1. The channels for volume transmission
The VT signals diffuse within the ECF of the brain, and
features of the extracellular channels building up the extra-
cellular space therefore deeply affect VT. The extracellular
space is a porous fluid-filled space with a foam-like structure
(Nicholson and Sykova, 1998) that contains the migrating VT
signals, extracellular enzymes and the extracellular matrix,
where hyaluronan and lecticans are the major building blocks
that via protein–protein and protein–carbohydrate interac-
tions form a three-dimensional network modulating the
diffusion pathways of VT (Agnati et al., 2006b,c). Diffusion in
the ECS has been studied with a number of extracellular
tracers (Fenstermacher and Kaye, 1988; Nicholson, 2001;
Sykova, 2004). From such an analysis, diffusion in the
extracellular space can be characterized by the three para-
meters volume fraction α, tortuosity λ and clearance κ
(Nicholson and Phillips, 1981), see Fig. 9. These classical
diffusion parameters may be different among brain regions
and species and may be altered by neural activity, ageing and
in pathological conditions (Sykova et al., 1998; Sykova, 2004).
Fig. 9 – Electron micrograph of the extracellular space. The
classical diffusion parameters are depicted in colors as the
volume fraction α (red), the tortuosity λ (blue) derived from
D*=D/λ2, and the clearance κ (green). Modified from
Nicholson and Sykova (1998). Tortuosity shows the increase
in path length compared to a straight course (see text).
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cellular space) on average represents 20% of the brain volume
(Van Harreveld, 1972; Nicholson and Sykova, 1998) and has
been given the term volume fraction α. In the early days,
electron microscopic images had indicated the volume frac-
tion to be only 5%, however this was rather due to shrinkage
artefacts during fixation (Fig. 9).
Tortuosity λ: molecules migrating in the ECS are exposed to
obstacles which leads to an increase in path length compared
to a straight course (Fig. 9). This increase is characterized by
the tortuosity factor λ. The obstacles include the viscosity of
the extracellular matrix, the structural boundaries of nerve
and glia cells and chemical obstacles like electrical charges
(Rusakov and Kullmann, 1998). A rise of tortuosity decreases
the free diffusion coefficient D to an apparent diffusion
coefficient D* by the formula D*=D /λ2 (Nicholson and Sykova,
1998), leading to a slowing down of diffusion and thus a
reduction of VT.
Clearance κ: The clearance factor κ represents the overall
removal of molecules in the ECS as theymigrate towards their
targets (Fig. 9). Several mechanisms are in operation in the
clearance process, namely clearance through the brain–blood
barrier, clearance through the brain–cerebrospinal barrier,
catabolic enzymes in the ECS and uptake systems in the CNS
cells like reuptake transporters (Hoffman et al., 1998; Höistad
et al., 2002).
Recently it has been possible to quantify the classical
diffusion parameters in brain in vivo not only with the real-
time iontophoresis method (see Nicholson and Sykova, 1998),
but also with the dual-probe microdialysis technique (Höistad
et al., 2002; Chen et al., 2002), using an extracellular tracer, 3H-
mannitol, and dilute agar as a reference medium (dilute agar
prevents convection processes without affecting diffusion;
Nicholson and Phillips, 1981). In these experiments, diffusion
was studied using dual-probe microdialysis with continuous
delivery and recovery of 3H-mannitol for 2 h at different
concentrations with an interprobe distance of 1 mm in the rat
striatum (Höistad et al., 2002). The generated diffusion profiles
(concentration versus time curves) can be empirically ana-lyzed generating the quantitative parameters Cout2(ss) repre-
senting semi-steady state concentration levels, and t50%
representing the time required to reach the half of the semi-
steady state levels (Höistad et al., 2000, 2002). These empirical
data from the microdialysis diffusion curves were trans-
formed into quantitative tissue parameters using a mathe-
matical model elaborated in a companion paper (Chen et al.,
2002). A fitting programwas developed to fit the data from the
3H-mannitol diffusion curves with theoretical curves, based
on the equation for diffusion in the brain developed by






This diffusion equation, which states that the change in
concentration C over time is faster the larger the concentra-
tion gradient, was applied to the dual-probe microdialysis
setting (Chen et al., 2002; Eqs 2 and 10):
BCe1=Bt ¼ and BCe2=Bt ¼
thus expressed for the two probes separately. These equations
were then solved to give the extracellular concentration in
space and time (Chen et al., 2002; Eqs 5 and 14):
Ce1ðr; tÞ ¼ and Ce2ðr; tÞ ¼
Performing simulations by varying the classical diffusion
parameters will show how such variations would affect the
diffusion curves (Chen et al., 2002; Höistad, 2004). The major
advantage of the dual-probe microdialysis technique versus
the real-time iontophoretic technique in diffusion experi-
ments is the ability to use a large number of highly relevant
molecules like transmitters and neuropsychopharmacological
drugs, in particular in awake animals, which cannot be
studied with the real-time iontophoresis technique (see
Höistad et al. (2002) and Höistad (2004)).
4.3.2. Dopamine diffusion in the striatum
Using the dual-probe microdialysis method as described
above, it was also tested whether intact 3H-DA would diffuse
over 1 mm in the rat striatum. However, depending on the
experimental conditions, we found that it was not possible
to detect diffusion of intact DA at the 1 mm distance after
the infusion of low nanomolar concentrations into the
delivery probe, either in the intact or dopamine denervated
striatum (Höistad et al., 2000). In agreement, Westerink and
De Vries (2001), also using microdialysis, demonstrated that
potassium-evoked striatal DA release could not be detected
at a 1 mm distance from the site of release. However, since a
substantial spread of DA has been observed in the striatum
after striatal micro-injections of high concentrations of DA
(Ungerstedt et al., 1969; Agnati et al., 1992), diffusion of 3H-
DA using dual-probe microdialysis may potentially have
been possible, if using higher infusion concentrations of 3H-
DA. Local diffusion of DA is well-known to exist in the intact
striatum as shown with voltammetry (Garris et al., 1994),
and DA transporters have been shown to reduce the
clearance half-life of extracellular DA (Wang et al., 1996;
Rice, 2000).
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transplants in dopamine denervated or intact striata also
suggest that DA operates via VT (Bjelke et al., 1988, 1989).
These transplants secrete prolactin which diffuses into the
surrounding neuropil and form a zone of prolactin IR (Fig. 10).
This zone is increased after DA denervation by injection of 6-
OH-DA into the substantia nigra and reduced by ampheta-
mine-induced DA release or by the injection of dopamine D2
receptor agonists like bromocriptine (Bjelke et al., 1988, 1989).
These results strongly indicate the existence of extracellular
DA in the striatum, which can diffuse into the transplant and
activate high-affinity D2 receptors on the prolactin containing
gland cells, resulting in the inhibition of secretion of prolactin
(Fig. 10). These studies also demonstrate that prolactin can
diffuse for long distances in the striatum, indicating that the
prolactin-like protein released from prolactin IR neurons in
the brainmay act as a long-distance VT signal. Also, studies on
host–graft interactions using adrenal medulla transplants and
embryonic midbrain transplants in the striatum indicate the
DA communication with WT and VT working together to
produce their anti-parkinsonian effects (see Strömberg et al.,
2000).
It is of interest that in DA denervated rats, dopamine
metabolites such as DOPAC and HVA were more rapidly
cleared from the extracellular space compared to control rats
after infusion of 3H-DA into the striatum (Höistad et al., 2000).
This may be due to an increased clearance of the DA
metabolites into the striatal capillaries after removal of the
DA terminals. In fact, it has been shown that DA terminals
may exert a vasoconstrictor action on the microvessels of the
brain (Iadecola, 1998). Thus, via VT dopamine released from
striatal nerve terminals may regulate striatal microcirculation
including its permeability.Fig. 10 – Illustration from thework of Bjelke et al. (1988, 1989)
of how striatal DA VT signals modulate the migration of
prolactin in the rat striatum after transplantation of
adenohypophyseal tissue containing prolactin cells with D2
receptors secreting prolactin into the striatal ECF. The halo
(area outside the transplant) of prolactin immunoreactivity
(A, control rats) is markedly increased after striatal DA
denervation (B) due to removal of DA VT signals inhibiting
the secretion of prolactin via activation of high-affinity D2
receptors on the prolactin secreting cells. (C) Amphetamine
treated rats show a decreased halo of prolactin
immunoreactivity due to the activation D2 receptors on the
prolactin cells by the high dopaminergic tone of VT.4.3.3. Fluid movements within the extracellular space
Tracer diffusion in the CNS can follow either an isotropic or
anisotropic diffusion pattern (see Fuxe and Agnati, 1991a,b).
Anisotropic diffusion in white matter has been demonstrated
by magnetic resonance imaging in cats and humans (Le Bihan
et al., 1993). Such a pattern is the consequence of the existence
of preferential diffusion pathways in the CNS along myeli-
nated fiber bundles and paravascular spaces (Brightman, 1965;
Blasberg et al., 1975; Rennels et al., 1985, 1990; Fenstermacher
and Kaye, 1988; Ichimura et al., 1991; Zhang et al., 1992; Bjelke
et al., 1995; Geer and Grossman, 1997; Vorisek and Sykova,
1997).
The preferential diffusion along paravascular spaces has
been shown to be facilitated by pressure gradients caused by
the pulsations of arterioles (Greitz, 1993; Greitz et al., 1993).
This leads to convective movements with mass movement
of the fluid carrying informational signals and increases the
rate of migration and thus VT signaling. Temperature
gradients in the brain also give rise to convective movements
in the extracellular fluid and therefore speed up VT. Of
special importance are large temperature gradients that
develop between inactive and active brain regions (Yablons-
kiy et al., 2000) and increase VT migration over large
distances, while at the same time mixing and renewing
extracellular fluid and improving homeostasis. Such large
temperature gradients are initially brought about by the
necessity to cool down the active brain regions by increasing
cerebral blood flow to the active brain region in view of the
lower temperature of peripheral blood. The sequence of
events may be that an increased neural activity in the active
brain region releases vasoactive signals that modulate the
arteriolar compliance and thereby increase the cerebral
blood flow in the active region (Behzadi and Liu, 2005).
Among the signals that may lead to an elevated cerebral
blood flow and facilitating temperature gradients, plasma/
ECF exchange, ECF renewal and thus VT migration, CO2 is of
special interest since it is formed in increased amounts not
only as a result of increased cellular metabolism in the
active region, but also by being released by active axons as a
highly diffusible VT signal (Agnati et al., 1995). Based on the
existence of carbonic anhydrase II immunoreactivity in
widespread systems of oligodendroglia and restricted astro-
glia populations in brain, it seems likely that axonal CO2 can
reach this enzyme and be converted into protons and HCO3
with the pH shift leading to changes in ion channel and
enzyme activities (Agnati et al., 1995). Thus, CO2 as a VT
signal may in this way increase not only the cerebral blood
flow, but also the excitability of the neuronal networks
surrounding the fiber bundles and the permeability of the
associated capillary networks in the active brain region. It is
clear that VT can be importantly driven by modifications of
metabolism in discrete neural networks of high activity, with
the development of large temperature gradients where CO2
VT transmission plays an important role.
Recently, brain uncoupling proteins (UCPs) have been
discovered and shown to generate heat by producing a
disappearance of the H+ gradient in the mitochondria (see
Horvath et al., 2003). Such uncoupled mitochondria predict
thermal synapses (Horvath et al., 1999) and neuroprotection
(Horvath et al., 2003; Andrews et al., 2006). We have now
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distances by producing small temperature gradients. Thus, in
the DA/D1 mismatch region of the nucleus accumbens shell,
an important region for reward, strongly UCP2-like IR com-
partments are in good register with the DA terminal rich
compartments surrounding the D1 rich compartments lacking
DA terminals and UCP2-like IR (Fuxe et al., 2005; Rivera et al.,
2006; Agnati et al., 2006b). This chemical architecture is of
substantial interest since thermal gradients can develop by
UCP2 generation of heat only in the DA terminal rich region,
leading to increased release and migration of DA into the
mismatch compartment with diffusion distances up to 50–
100 μm. Thus, long-distance DA VT may be improved and put
into full operation by the thermal gradients generated by
UCP2. This organization could underlie the ability to predict
future reward responses (see Agnati et al., 2007 andGuidolin et
al., this issue). The spatio-temporal relationships of the rapid
WT and slow VT acting on the nerve cells of the D1 receptor
mismatch region could lead to sensitization of these nerve
cells to the exact time of the delivery of the reward following a
predictive sensory cue.
Strong UCP2-like IR has also been found in discrete DA and
NA terminal systems specialized for VT, with large varicosities
in the cerebral cortex (DA) and the neostriatum (NA) (Rivera et
al., 2006). UCP2-like IR was also present in DA and NA cell
bodies and dendrites (Horvath et al., 1999, Fuxe et al., 2005;
Rivera et al., 2006), where UCP2may enhance VT by enhancing
DA and NA release and migration to activate D2 and α2
autoreceptors.
4.3.4. The cerebrospinal fluid system as a communication
channel
Based on MR imaging and radionuclide cisternography, it has
been proposed that the production and absorption of CSF may
occur via the brain capillaries, with direct CSF transport into
the blood stream involving the paravascular spaces and the
ECS of the brain (Greitz, 1993), which contributes to the bulk
flow of ECF and generates energy gradients to enhance VT
migration (see Agnati et al., 2006b). Also, the ventricular
ependyma does not possess tight junctions and shows
enrichment of aquaporin-4 through which water can pass,
and thus allows the exchange of VT signals between the ECF
and the CSF (Fenstermacher and Patlak, 1974; Brightman and
Kaya, 2000; Lippoldt et al., 2000a,b).
Greitz et al. (1991, 1993) have proposed that the intracranial
arterial pulses produce pulsatile movements in the CSF
involving “piston” movements of the brain. Based on this
work, the existence of cyclic pressure oscillations also within
the subarachnoidal space has been assumed, and the “tide”
hypothesis of VT signal migration, clearance and modulatory
signal release has been introduced (Agnati et al., 2005a, 2006b).
This hypothesis states that cyclic pressure oscillations exist
within the subarachnoid space inducing “tide” movements
(renewal of fluid like in a sponge) in the fluid of the Virchow–
Robin spaces of the cerebral cortex, and subsequently of the
paravascular and pericapillary spaces and eventually in the
ECF. Such convective movements caused by the pressure
gradients of the arterial pulse will enhance VT migration and
improve the homeostasis of the internal milieu of the brain,
especially of the cerebral cortex.Already in the 1970s, the CSF was proposed to play a
significant role in brain communication (Morris et al., 1975),
and this proposal has received further support (Bloom and
Segal, 1980; Jackson, 1980; Kiser et al., 1983; Proescholdt et al.,
2000). Furthermore, especially the peptides in the CSF have
been regarded as information signals, which are altered in
neuropsychiatric disease (Burbach, 1982; Post et al., 1982). A set
of criteria have been developed for the identification of a CSF
signal acting at distant target cells (Nicholson, 1999). These
include:
– Themessenger is found in the CSF in quantifiable amounts.
– The concentration varies with the physiology of interest in
an appropriate manner.
– Removal of the messenger disrupts the physiology.
– Excess amounts affect the physiology.
– Production of the substance is upstream (in terms of CSF
flow) from the receptor site.
– The target cell detects the messenger and transduces this
signal to a biological response.
The CSF signals are regarded as long-distance VT signals
globally modulating brain and spinal networks via their
receptors (see Fuxe and Agnati, 1991a,b; Agnati et al., 2000a).
It should be considered that VT communication via CSF has a
special importance in brain development, especially prior to
the synapse formation (Miyan et al., 2003). In adulthood, a
number of biologically activemolecules have been proposed to
represent CSF signals (Segal, 2000; Brightman and Kaya, 2000).
Of special interest are molecules affecting global functions
such as sleep and circadian rhythms (Silver et al., 1996; Skinner
and Malpaux, 1999), interleukin-1β modulating inflammation
and sickness behavior (Krueger andMajde, 1995; Jansson, 1999;
Jansson et al., 2000) and β-endorphin being essential for self
and species survival (Akil et al., 1978; Bloom et al., 1978; Agnati
et al., 1986a; Fuxeet al., 1988a; seeHöistadet al., 2005). For a role
of CSF signals in diseases of the nervous system, see Fishman
(1992).5. The integration of WT and VT via
receptor–receptor interactions
Wiring transmission includes not only synaptic transmission,
but also gap junctions and membrane juxtapositions (see
Shepherd, 1991, 1994). For a recent review of the morpho-
functional organization of WT communication, see Agnati et
al. (1986a). Special gap junctions are the electrical synapses,
and the existence of mixed synapses should be underlined
where both electrical and chemical transmissions take place
(Nagy et al., 2004).
The differential properties of WT and VT are summarized
in Tables 1 and 2 (see Agnati et al., 1986a, 2006b; Fuxe and
Agnati, 1991a; Agnati and Fuxe, 2000). As discussed (Agnati et
al., 1994), there exist two classes of VT signals: the private code
signals represented by transmitters, and the open code signals
represented by electrical signals (ions). Any nerve cell by its
electrical activity can modulate any other cell within the
micrometer range through ion fluxes in the ECF. Hydrophilic
transmitters like monoamines and peptides diffuse in the ECF
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activation of membrane receptors, while hydrophobic trans-
mitters like NO have a preferential local role in VT by diffusing
across cell membranes in an isotropic manner to activate
intracellular effectors.
Slow high-affinity G-protein-coupled receptors are the
major molecular target for VT signals. They decode the VT
signal and modify the cell function. All central neurons are
therefore under the influence of VT signals, which are
continuously integrated with WT signals not only at the
cytoplasmatic and nuclear level but also at the plasma
membrane level. The mechanism for the integration at the
membrane level may mainly be represented by intramem-
brane receptor–receptor interactions, mainly represented by
slow high-affinity G-protein-coupled receptors and synaptic
receptors, represented by both fast ion channel linked recep-
tors and slow G-protein-coupled receptors (see Fuxe and
Agnati, 1985; Agnati and Fuxe, 2000; Agnati et al., 2003a; Ciruela
et al., 2006; Fuxe et al., 2007). Such an integration ofWT and VT
signalsmaybe themolecularmechanism for theappearance of
polymorphic networks (see Agnati and Fuxe, 2000).
Evidence for this view now exists since it has been
demonstrated that DA operating via VT can fine-tune the
excitatory and inhibitory WT in the brain via direct receptor–
receptor interactions. The molecular mechanism is the forma-
tion of different types of DA receptor mosaics representing
heteromeric receptor complexes of DA receptor subtypes (VT)
and ion channel (WT) or other GPCR receptors (VT) (see Table 4).
The following DA receptor mosaics containing ion channel
receptors have been demonstrated: GABAA/D5 (Liu et al., 2000),
NMDA/D1 (Lee et al., 2002a,b), and D2/NR2B (Liu et al., 2006).
Intramembrane receptor–receptor interactions at the level of
the D2 binding pocket have also been observed between GABAA
andD2 receptors in striatalmembranes, indicating that also this
type of DA receptor mosaic may be formed (Perez de la Mora et
al., 1997). The D2 autoreceptor/nicotinic heteromeric receptor
complexes also exist in the striatal DA terminals (Quarta et al.,
2007), and the work of Li et al. (1995) discussed the possible
existence of direct interactions between nicotinic receptors and
DA receptors in the basal ganglia.Table 4 – Receptor mosaics
Reference
SSTR5/D2R Rocheville et al., 2000
A1R/D1R Gines et al., 2000
A2AR/D2R Hillion et al., 2002
Canals et al., 2003
Kamiya et al., 2003
GABA-A R/D5R Liu et al., 2000
GABA-A R/D2R heteromeric
complexes
Perez de la Mora et al., 1997
NMDAR/D1R Lee et al., 2002a,b
A2AR/D3R Torvinen et al., 2005
D2 autoreceptor/nicotinic receptor
heteromeric complexes
Li et al., 1995
Quarta et al., 2007
NMDAR/D2R Liu et al., 2006
Dopamine receptor containing heteromeric receptor complexes
built up of transmitter/modulator receptors activated by different
ligands.5.1. Hypothesis on receptor–connexin interactions in
mixed synapses: a possible mechanism for integration
between two types of WT
The co-localization of chemical and electrical synapses
enables interactions between them that assist in the activity
synchronization of central neurons (Tamas et al., 2000), and
numerical and analytical techniques indicate that chemical
and electrical synapses have complementary roles in the
synchronization of interneuronal networks (Kopell and
Ermentrout, 2004). It seems possible that the leak of synaptic
currents across the electrical synapse diminishes the ampli-
tude of the synaptic responses, and indications have been
obtained that electrical synapses by modulating the EPSPs of
chemical synapses can regulate the neuronal firing rate
(Garcia-Perez et al., 2004).
To understand the function of mixed synapses, it should
be noted that there may exist within them a short-term
enhancement of intercellular coupling dependent on activ-
ity (Pereda and Faber, 1996), and Ca2+/calmodulin-depen-
dent kinase II can at the same time produce an increase of
gap junctional conductance and of glutamate transmission
in mixed synapses (Pereda et al., 1998). These findings
indicate that the electrical component of the mixed
synapse may undergo a form of potentiation similar to
LTP, which may e.g., be essential for synchronization of
oscillations of high frequency (see Nagy et al., 2004). Based
on the work on intramembrane receptor–receptor interac-
tions discussed above (see Agnati et al., 2000b, 2005b; Fuxe
et al., 2003a, 2007), involving the formation of various types
of receptor mosaics containing G-protein-coupled receptors
and/or ion channel linked receptors, we now introduce the
hypothesis that mixed synapses are formed to enable direct
receptor–connexin interactions, which inter alia may help
explain the LTP like phenomena observed in the gap
junctions (Fig. 11). Activation of the receptor, of e.g., one
of the glutamate receptor subtypes, may produce conforma-
tional changes of the gap junctions, namely in the
participating connexin36, connexin45 or connexin57 pro-
teins, depending on the neuronal subtype, and the same
may also be true for pannexin 1 and 2 proteins, also
forming electrical synapses (Sohl et al., 2005; Nagy et al.,
2004). Such conformational changes in connexin and
pannexin proteins may lead to alterations in the electrical
conductance either by themselves and/or by altering the
availability of different types of kinases to the cytosolic
parts of the connexin and pannexin proteins, like Ca2+/
calmodulin-dependent kinase II (Fig. 11).
Such receptor–protein interactions may probably be recep-
tor and protein subtype specific and exist both pre- and
postsynaptically, based on the previous work on receptor–
receptor interactions (see above). Dependent on themolecular
composition, three types of gap junctions likely exist,
described as heteromeric, heterotypic and homomeric/homo-
typic (see Sohl et al., 2005). The homomeric or heteromeric
hemichannels are built up of one or more connexin (or
pannexin) isoforms, respectively. The homotypic or hetero-
typic gap junctions consist of two identical or two different
hemichannels, respectively. Each hemichannel consists of six
connexin protein subunits. It is of interest that the connexin
Fig. 11 – Illustration of the present hypothesis on receptor–connexin (or pannexin) interactions. Synaptic WT and VT may
regulate fast WT through gap junctions in e.g., electrical synapses and mixed synapses, via a molecular mechanism causing
changes in the conductance of the gap junction channels. There could exist a direct interaction with hemichannels with the
formation of heteromeric complexes of receptors and connexin protein subtypes (or pannexin protein subtypes). Indirect
interactions with hemichannels could also exist via phosphorylation/dephosphorylation mechanisms. Both mechanisms
could exist in parallel to fine-tune the fast WT via gap junctions.
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terminal tail.
These domains are therefore of special interest when
exploring possible subtype specific receptor–connexin protein
interactions, considering connexin36, 45 and 57 proteins
known to exist in the electrical synapses. It is also reasonable
that the heteromeric versus homomeric electrical synapses
can differentially participate in the receptor–connexin (pan-
nexin) interactions. Another type of receptor–connexin inter-
action could be via a receptor modulation of the dynamic
trafficking and delivery of connexons (assembly of six
connexin proteins forming a hemichannel on one side of the
gap junction channel) to the plasma membrane (Lauf et al.,
2002). Thus, the receptor signaling may alter the gene
expression of the connexin proteins, and receptors may form
heteromeric complexes with the connexons or pannexons.
The receptors may also alter the accrual of connexons or
pannexons to the outer margins of the gap junction channel
clusters and in this waymodulate the strength of the electrical
synapses.
It should be considered that a differential expression of
the three gap junction proteins exists in brain development
versus the adult brain (Dermietzel et al., 1989; Bruzzone and
Dermietzel, 2006). Therefore, also receptor–connexin inter-
actions may differ in brain development compared with
adult brain. Recently, axo-axonal coupling has been intro-duced as a new mechanism for ultrafast neuronal commu-
nication (Schmitz et al., 2001). In view of the existence of
receptors on pre-terminal axons (Riad et al., 2000; Jansson
et al., 2002), receptor–connexin (or pannexin) interactions
may also exist here, modulating this ultrafast neuronal
communication.
5.2. On the role of WT and VT and their integration in the
monoamine neurons
5.2.1. The nigro-striatal dopamine system
In 1983, Grace and Bunney demonstrated in adult rats dye
coupling between nigral DA cells, suggesting that functional
gap junctions may exist between them (Grace and Bunney,
1983). This indicated a new mechanism for regulation of DA
cell firing via very fast WT besides their inhibitory regulation
by D2 autoreceptors (Skirboll et al., 1979). Twenty years later,
juvenile rats were shown to express connexin proteins in DA
cells of the midbrain (Leung et al., 2002), strengthening the
possibility that synchronous burst firing of DA nerve cells,
strongly enhancing VT in the DA terminal networks (Gonon,
1988), may be promoted by electrical synapses (very fast WT).
Recently, functional electrical synapses between nigral DA
cells were demonstrated in the postnatal period using dual
whole-cell patch cell recordings, which correlated with tracer
coupling analysis (Vandecasteele et al., 2005). However,
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become synchronized, which may be related to the need of
non-pulsatile and constantly maintained DA VT in the striatal
target region. The impact of the very fast WT, however, was
made evident by the fact that the slow nigral DA VT, with
dendritically released DA activating inhibitory D2 autorecep-
tors, could not block the ability of one depolarizing DA cell to
enhance the spontaneous firing rate of its electrically coupled
DA neuron. Nevertheless, only 27% of the tonically active DA
neurons show synchronization of their activity (Morris et al.,
2004).
Again, to understand the interaction between the very fast
WT and slow DA VT in the substantia nigra, the existence of
D2-like autoreceptor–connexin protein interactions should be
seriously considered. It may be that the DA VT via such inter-
actions can uncouple the electrical synapses so efficiently that
only a limited number of tonically active DA neurons can
present a synchronous firing. However, it is important to note
that in mathematical models of DA cell pairs, considering also
excitatory NMDA mediated glutamate synaptic transmission,
the electrotonic coupling is strongly predicted to promote
synchronous phasic firing (Komendantov and Canavier, 2002),
in agreement with the work on electrotonic coupling in the
locus coeruleus discussed below.
Thus, it seems likely that very fast WT involving electrical
synapses in the nigral DA cells via promotion of synchronous
burst firing in clusters of nigral DA cells can enhance VT in the
striatal DA terminal networks through the resulting brief
peaks of DA release. DA pulses of longer duration using
microdialysis have also been detected (Agnati et al., 2000b). In
early Parkinson's disease, the reduction of DA VT in the
substantia nigra due to degeneration of certain DA cells may
lead to an increase in synchronous phasic firing of the DA
cells, due to enhancement of activity in the electrical synapses
as discussed above. This can substantially underlie the
increases in striatal DA release and turnover observed in
models of Parkinson's disease (see Fuxe, 1979; Zigmond, 2000),
which serves to increase DA VT in the terminal plexa to
compensate for the reduction of DA transmission (Fuxe and
Agnati, 1991a). As the disease progresses, however, also the
electrical synapses between DA cells will be reduced, dimin-
ishing this compensatory upregulation, since the increased
synchronous phasic firing will fade and clinical symptoms
develop.
5.2.2. The locus coeruleus noradrenaline system
As discussed, the major mode of communication of the
locus coeruleus NA terminal networks in the widespread
target regions of the CNS is VT, which via diffusion of NA
globally modulate the activity and metabolism of large cell
populations (see Fuxe and Agnati, 1991a,b). One way to
increase VT in the widespread NA terminal networks would
be synchronous activation of the NA nerve cells of the locus
coeruleus, which also would represent an elegant way to
regulate NA tone in the target areas (Christie et al., 1989;
Aston-Jones et al., 1991). Such a synchronous activation
could be brought about by an electrotonic coupling between
the LC NA nerve cells via neuronal gap junctions represent-
ing a very fast form of WT. The first observations to sup-
port such a mechanism were made by Christie et al. (1989)showing based on paired recordings that electrotonic
coupling synchronizes subthreshold activity in LC NA cells
in vitro from neonatal rats. The coupling caused the
synchronized occurrence of membrane potential oscilla-
tions, with the appearance of rhythmic background activity
in the entire LC which became reduced with increased age.
Later on, dye coupling among the LC NA cells could be
demonstrated in the postnatal period (Christie and Jelinek,
1993).
In an analysis of opioid inhibition of the LC of neonatal rats
using also agents blocking electrotonic coupling (Travagli et
al., 1995), further support was obtained for the existence of
electrotonic coupling among LC NA cells. Such a mechanism
was proposed to facilitate inhibition by opioid peptides of LC
cells, in addition to synchronous activation as previously
proposed. In fact, morphine has been shown in vivo to reduce
discharge and to enhance the burst firing pattern of LC cells in
awake animals (Aston-Jones et al., 1992). However, electro-
tonic or dye coupling could not be demonstrated in adult rats,
unless made under certain conditions.
Subsequently, synchronous activity in LC cells could be
demonstrated in adult rats and shown to depend on electro-
tonic coupling between LC NA dendrites in peri-coerulear
regions, using gap junction blockers which reduced synchro-
nization without blocking electrical activity (Ishimatsu and
Williams, 1996). The dendritic tree has been shown to extend
beyond the NA cell body region (Shipley et al., 1996). The
findings indicate that the electrotonic coupling in the LC may
mainly serve to increase synchrony upon arrival of a strong
excitatory input. In 2000, LC neurons and astroglia were also
shown to be electrotonically coupled by the presence of
electrical and tracer transfer between the two types of cells
including the presence of gap junction proteins (Alvarez-
Maubecin et al., 2000). In agreement, selective depolarization
of glia by activation of glutamate transporters indirectly
increased LC NA cell activity.
Thus, the evidence discussed above indicates that simul-
taneous increases in NA VT in the widespread target areas of
the LC may be made possible by synchronization of the LC
activity through electrotonic coupling and synaptic transmis-
sion representing very fast and fastWT, respectively. It should
be considered that themolecular mechanism discussed above
on the existence of receptor–connexin interactions could
assist in the strengthening of the electrotonic coupling, and
thus in the synchronization of the LC NA cell firing. The
relevance of synchronization viaWT in the LC ismade clear by
the correlation of periods of high performance in a behavioral
task with increases in phasic LC activity, shown to be
synchronous in paired recordings (Usher et al., 1999).
Thus, through increased WT in the LC leading to synchro-
nization of the LC NA cells, the LC NA terminal networks can
become optimally activated at the same time in the different
widespread target regions, including especially the entire
cerebral and cerebellar cortex, and via increased NA VT
activate the various adrenergic subtypes in the vast numbers
of neuronal and glial cell populations, including also other
non-neuronal cells. In this way, LC can via WT and VT
function optimally as a survival system enhancing arousal,
attention and behavioral and cognitive performance. The
sleep–wakefulness function is characterized by a latency, a
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regulated by the slow VT in the LC NA neurons, modulating
entire networks with the reset of the activity of widespread
cellular networks of several target regions.
In view of the above, it seems likely that a dysfunction of
the LC NA system may contribute to attention deficit
hyperactivity disorders (ADHD). It should be considered that
also the precursor DA is released from the cortical NA nerve
terminals and may via VT reach and activate dopamine D4
receptors located on pyramidal and non-pyramidal nerve cells
found all over the cerebral cortex (Rivera, Fuxe et al.,
unpublished data). In addition, these receptors have a high
affinity for NA (Newman-Tancredi et al., 1997), and the D4 IR is
in fact more closely related to the widespread NA terminal
plexa than the restricted DA terminal plexa (Rivera, Fuxe et al.,
unpublished data). The diffusing DA fromNA nerve terminals,
besides the DA from the meso-cortical DA neurons, may also
reach D2-like receptors in the prefrontal cortex, which when
stimulated causes an inhibition of locomotor activity (see Del
Arco et al., 2007). Such VT mechanisms in cortical DA and NA
communication likely explain why psychostimulant drugs
releasing DA and NA are successfully used in the treatment of
ADHD.
5.2.3. The dorsal raphe 5-HT neuron system
As discussed, the serotonergic system has been shown to play
a major role in mood regulation, and the widespread 5-HT
terminalnetworks operatemainly viaVT to reset the activity of
many cellular networks of the tel- and diencephalon, espe-
cially in the cerebral cortex. It is of substantial interest that, in
the developing somatosensory cortex, 5-HT receptors can
reduce gap junction coupling (Rorig and Sutor, 1996). It was
found that 5-HT reduced the dye coupling in pyramidal cells
via 5-HT2 receptors, and the uncoupling was blocked by IP3
receptor antagonists andPKC inhibitors (Rorig andSutor, 1996).
Thus, at least in development, 5-HT via VT can modulate gap
junctional transmission and thus WT in the differentiating
neocortex. It may be suggested that themolecular mechanism
may involve 5-HT2–connexin protein (or pannexin) interac-
tions, permitting integration of VT and WT.
Like in the locus coeruleus, it is of interest to know if there
exist in the 5-HT cell bodies in the nucleus raphe dorsalis a
mechanism to synchronize the firing rate of the 5-HT cells to
enhance at the same time 5-HT release and VT in several
target regions. The firing pattern of 5-HT cells is characterized
by slow, regular spontaneous discharge rates of 0.5–3 Hz
(Aghajanian and Haigler, 1974). In 1982, their correlative firing
patterns were analyzed, and adjacent 5-HT cell pairs showed
correlated discharges within a short time frame below 10 ms.
Thus, a synchronous firing pattern was observed between
adjacent 5-HT nerve cells (Wang and Aghajanian, 1982). The
mechanism was, however, unclear at this time. In 1975,
dendro-dendritic gap junctions were observed in the develop-
ing dorsal raphe nucleus (Möllgard and Möller, 1975), and
dendrite bundles were observed in this 5-HT cell rich nucleus
(Felten and Harrigan, 1980), where gap junctions could be
formed.
In 1995, dye coupling between dorsal raphe neurons from
young adult rats was discovered probablymainly occurring via
dendro-dendritic gap junctions (Stezhka and Lovick, 1995).The results suggested a substantial level of electrotonic
coupling between dorsal raphe cells, which may be the
major mechanism for synchronous firing of the 5-HT nerve
cells. In support of this view, a high degree of synchrony of
firingwas observed in pairs of dorsal raphe 5-HT cells (Hajos et
al., 1994). Thus, very fast WT may exist in the dorsal raphe 5-
HT cell assembly to produce synchronization of firing of
clusters of 5-HT nerve cells, enhancing 5-HT VT in several
target regions (Fuxe and Agnati, 1991a,b), and in this way
counteract the lowering of mood and the development of
depression.
Indications of 5-HT release in the nucleus raphe dorsalis
were obtained early (Fuxe and Ungerstedt, 1970; Hery et al.,
1982), and 5-HT receptor activation within the nucleus could
cause the inhibition of firing observed under conditions of
increased extracellular 5-HT (seeWang and Aghajanian, 1982).
In 1986, vesicle containing dendrites were observed in the
nucleus raphe dorsalis in the cat, indicating dendritic release
of 5-HT in this nucleus (Chazal and Ohara, 1986). It is
suggested based on the findings of Rorig and Sutor (1996)
and on the above discussion that activation of dendritic 5-HT
receptors via 5-HT receptor–connexin interactions can uncou-
ple the dendritic gap junctions, which then no longer can
promote the synchronous bursting actions of excitatory
glutamate inputs. Such a mechanism can contribute to the
inhibition of firing observed. Thus, a novel mechanism for
depressionmay be by producing deficits in the very fastWT in
the 5-HT cell clusters of the dorsal raphe, through interference
with the neuronal gap junction conductance, in this way
reducing synchronization and phasic firing. 5-HT VT in the
dorsal raphe may contribute to such deficits in very fast WT.6. Conclusions
(i) The work on the monoamine neurons has over many
years strongly contributed to giving experimental
evidence for the existence of VT in the brain and spinal
cord and has contributed to the development of the
theory of how VT and WT in complementary ways
operate in central neurons.
(ii) The same principles of communication appear to exist
in all the three monoamine neurons, with electrical and
chemical synapses interacting with monoamine VT
signals in clusters of monoamine cell bodies to produce
synchronous bursting activity to strongly enhance the
monoamine VT in the widespread terminal plexa of
many target regions. In this way, an optimal function of
the DA, NA and 5-HT neuron systems can be obtained.
(iii) The WT and VT modes of communication interact via
direct or indirect receptor–receptor interactions at the
membrane, cytoplasmic and nuclear levels in the
cellular circuits.
(iv) GPCR/RTK receptor interactions may play a crucial role
in mediating the GPCR-mediated VT signaling in
neuronal plasticity and trophism, as exemplified in 5-
HT VT and depression.
(v) The hypothesis is introduced that electrical synaptic
transmission (very fast WT) can be integrated with VT
and chemical synaptic transmission (fast WT) via
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which may be fundamental in understanding the
regulation of synchronous burst activity in the trans-
mitter-identified cell body clusters.
(vi) Knowing the integration of WT and VT will be funda-
mental for the understanding of brain function in health
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